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Angioblasts, the precursor cells that give rise to the endothelial layer of
blood vessels, arise from a purely mesodermal population.  Individual angioblasts
coalesce to form the primary vascular plexus through a process called
vasculogenesis.  A number of reports in the literature suggest that signals from the
adjacent endoderm are necessary to induce angioblast specification within the
mesoderm.  We present evidence, using both embryological and molecular
techniques, indicating that endoderm is not necessary for the induction of
angioblasts.  While Xenopus embryos lacking endoderm contain aggregates of
angioblasts, these angioblasts fail to assemble into endothelial tubes.  Endothelial
tube formation can be rescued however, by implantation of endodermal tissue
from sibling embryos.  Based on these studies in Xenopus, and corroborating
experiments using the quail embryo, we conclude that endoderm is not required
vii
for angioblast specification, but does provide an inductive signal for vascular
assembly.
In additional experiments using avian embryos, we demonstrate the
molecular identity of this inductive signal, showing that endodermally derived
Sonic Hedgehog is both necessary and sufficient to form endothelial tubes from
angioblasts in avian embryos.  This demonstrates a novel role for hedgehog
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Chapter 1:  Molecular Vascular Embryololgy1
1.1. INTRODUCTION
The establishment of an intact, functional cardiovascular system is a prerequisite
for embryonic development in vertebrates.  A diagram showing the location of the
major blood vessels in the embryonic cardiovascular system is presented in Fig. 1.
The importance of this system for delivering oxygen and nutrients to developing
tissues is underscored by the early embryonic lethality of embryos deficient in
essential cardiovascular genes.  Despite a spatiotemporal correlation between the
formation of the cardiac and vascular structures, these two systems undergo
autonomous developmental programs.  In fact, an intact vascular system will form
perfectly well in the absence of a beating heart (Knower, 1907; Chapman, 1918).
Over the last hundred years, vascular development has been extensively studied
by classical embryologists who described the formation of the first blood vessels.
However, the absence of early vascular markers, especially markers for vascular
endothelial precursor cells (angioblasts), greatly impeded studies aimed at
understanding the initial events underlying vascular development.  With the
advent of molecular biology, it has been possible to study the early events in the
formation of the vascular system in greater detail, and to start characterizing the
genetic pathways underlying these processes.
                                                 
1 This chapter, including all figures, is a revised and edited version of a book chapter reproduced
with permission from Springer-Verlag.  Vokes, S.A. and Krieg, P.A. (2002) Molecular Vascular
Embryology. In: Lanzer, P. and Topol, E. (eds) PanVascular Medicine, Integrated Clinical
Management. Springer-Verlag, Berlin Heidelberg New York, pp 18-35.
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Figure 1.  Schematic representation of the vascular system of a
mammalian embryo.
For simplicity only the major vessels are shown.  Moreover, only one of the
paired dorsal aortae and one of the posterior cardinal veins is illustrated.  This
simple vascular plexus will undergo extensive remodeling during later
development to form the mature vascular system.
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Embryonic vascular development can be divided into a number of distinct
steps.  The first event is the specification of angioblasts from the mesodermal cell
layer of the embryo.  The second step is the assembly of these free angioblasts
into vascular cords followed by formation of the vascular tube.  Third is the
elaboration of the initial vascular plexus by outgrowth from existing vessels.  The
final step in the process is the recruitment of vascular smooth muscle cells to the
outside of the endothelial tube.  It is the properties of these smooth muscle cells
that ultimately define the physical and biochemical properties of the resulting
artery or vein.  As will be described in more detail in the following sections,
specific genes can now be associated with the regulation of each of the different
steps in vascular development.  Although our knowledge of the celluar and
molecular mechanisums underlying the functions of these genes is still quite
sparse, the importance of these studies is clear, since mutations in these pathways
are known to underlie congenital vascular disorders in human patients.
1.2.  EMBRYOLOGY OF VASCULAR DEVELOPMENT
1.2.1.  General introduction to embryology
As a result of the process of gastrulation, cells within the embryo become
divided into three distinct tissue layers, often referred to as the germ layers.
These layers are named ectoderm, mesoderm and endoderm, corresponding
respectively to the outer, middle and inner layers of the developing embryo.  In
broad terms, the ectoderm gives rise to the skin and neural tissues, while the
mesoderm differentiates into a number of tissues, including the kidneys, heart,
blood, muscle and endothelial cells.  Endoderm forms the liver, lungs, pancreas
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and the lining of the gut.  During early development, the primary tissue layers
become subdivided into different regions.  For example, the outer layer of
mesoderm, adjoining the ectoderm is called the somatic mesoderm, while the
inner layer adjacent to the endoderm is referred to as the splanchnic mesoderm.
These different layers of mesoderm generally develop into distinct tissues.  For
example, portions of the splanchnic mesoderm develop into cardiac muscle while
the somatic mesoderm contributes to the lateral and ventral body wall.
During development, interactions between the different germ layers
(usually called inductive interactions) are crucial for establishment of the complex
range of organs and tissues that will comprise the mature organism.  In molecular
terms these interactions often involve the activation of signaling pathways via
growth factors or cell surface effectors.  Perhaps the most important example of
embryonic induction is the formation of neural tissues.  In this case, a certain
subset of the ectodermal cell layer is induced to form neural tissue through
interactions with the mesoderm.  The actual processes underlying tissue
specification and embryonic induction are complex, but are described in great
detail in other sources (Gilbert, 2000; Wolpert et al., 1998).
1.2.2.  Vasculogenesis
The primary network of blood vessels in the embryo is formed by the
process of vasculogenesis, which is defined as the de novo formation of blood
vessels by the aggregation of individual angioblasts (Fig. 2).  At a fundamental
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level, this process involves both the specification of endothelial cell precursors
(angioblasts) from mesoderm and then the coalescence of these angioblasts into
endothelial tubes.  Independent of the events of angioblast specification, some
researchers have found it convenient to distinguish two variants of
vasculogenesis.  In Type I vasculogenesis, blood vessels form from angioblasts
that arise in place, i.e. the vessels assemble at the position where the angioblasts
are first detected.  Type 2 vasculogenesis occurs when individual angioblasts
migrate over some significant distance to a new location where they then
assemble into a blood vessel (Poole and Coffin, 1991).  It should be emphasized
that migrating angioblasts that contribute to previously formed blood vessels are
not examples of Type 2 vasculogenesis because vascular formation has already
occurred.  After the delineation of the primitive vascular network via
vasculogenesis, subsequent elaboration of the system of blood vessels occurs by
angiogenesis.  Angiogenesis is the sprouting or splitting of blood vessels from
pre-existing blood vessels (see below).  In summary therefore, the earliest
vascular development is achieved by vasculogenesis, while angiogenesis is the
only mechanism of blood vessel formation in later development.
The process of vasculogenesis was originally described by classical
embryologists who used histological methods to establish that angioblasts arise
from mesoderm and coalesce to form endothelial cords that subsequently become
patent blood vessels (His, 1868; Van der Stricht, 1895; His, 1901; Rückert and
 6
Figure 2. Diagramatic representation of the major events in vasculogenesis.
The basic process involves three steps: (A) specification of vascular precursors
(angioblasts) from embryonic mesoderm, (B) aggregation of angioblasts into cords, and
(C) lumen formation.  The result is the formation of the primary vascular plexus (D).
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Mollier, 1906; Dantschakoff, 1908; Stockard, 1915a; Sabin, 1920; Sabin, 1922).
These original studies demonstrated that, in amniotes, vasculogenesis occurs both
extraembryonically, in the yolk sac surrounding the embryo, as well as
intraembryonically.  In teleosts (bony fishes) and amphibians, vasculogenesis
occurs only intraembryonically (Stockard, 1915b).  A major difference between
extraembryonic angioblasts and intraembryonic angioblasts lies in their structure.
Extraembryonic angioblasts are found in blood islands, containing an outer layer
of endothelial cells and an inner layer of red blood cells (See Fig. 3).  In contrast
to the extraembryonic blood islands, intraembryonic endothelial precursors are
almost always first observed as solitary angioblasts (Risau, 1995) and only in rare
instances are they closely associated with blood cells.  Indeed the independence of
these two lineages has been demonstrated in Amphibia, where the entire blood
forming region of salamanders can be surgically removed without significantly
altering the endothelial network (Goss, 1928).  At present it is unclear whether the
differences in endothelial cell origins observed between the intra and
extraembryonic vasculature reflect fundamental differences in the processes of
vascular cell development between these systems, or whether intra and
extraembryonic vasculogenesis occur in a molecularly identical fashion.
1.2.3. The avian embryo
The events of embryonic vasculogenesis are better described in the avian
embryo than any other organism.  This is primarily because the embryonic
vascular system is easy to visualize and is readily accessible to experimental
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manipulation.  Anatomically, the chick embryo is comprised of an outer layer
called the area opaca which has yolk directly beneath it, the area pellucida, the
inner layer, which does not have yolk directly beneath it and is therefore
transparent.  Essentially, the area pellucida will form the embryo proper while the
area opaca will develop into the extraembryonic yolk sac ectoderm and endoderm
(Risau and Flamme, 1995; See Fig. 3).  Vascular development in the yolk sac
temporally precedes that of intraembryonic vasculogenesis.  Formation of the first
vessels is initially visible as an aggregation of mesenchymal cells in the
splanchnic mesoderm adjoining the extraembryonic endoderm in the middle of
the area opaca.  This vascularization quickly spreads throughout the entire area
opaca with the exception of the area anterior to the head and a small area at the
embryonic tail.  Together, the regions of the area opaca and area pellucida that
form blood vessels are termed the area vasculosa, which corresponds to the entire
area that contains mesodermal cells (Risau and Flamme, 1995).  After
specification, the angioblasts extend cytoplasmic protrusions towards each other
and then assemble into cords of angioblasts which subsequently form a
continuous strand of endothelial cells.  These cells will then form tubular vascular
structures.  It is important to note that extraembryonic blood vessels contain
primitive erythrocytes, while intraembryonic blood vessels are largely devoid of
erythrocytes (Sabin, 1920; Houser et al., 1961; Gonzalez-Crussi, 1971).
While His postulated that extraembryonic blood vessels might actually be
the source of endothelial cells that populated the chick embryo proper (His, 1868;
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Figure 3.  Intra and extraembryonic vascular development in chick embryos.
(A) The first extraembryonic blood islands appear at the head process stage, immediately
adjacent to extraembryonic endoderm.  A stylized blood island (shown in the boxed area)
contains future endothelial cells surrounding primitive erythrocytes.  The area vasculosa
comprises the entire region containing extraembryonic and intraembryonic mesoderm
and marks the area that will become vascularized.  (B) A 7-somite chick embryo contains
fused heart primordia, and the extraembryonic blood vessels connected to the
intraembryonic circulatory system through the vitelline veins.  The paired dorsal aortae
are the most prominent early blood vessels.  At this stage many other vessels are present,
but for simplicity have been ommited from the diagram.
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His, 1901), this was refuted by subsequent experiments (Hahn, 1909; Miller and
McWhorter; 1914; Reagan, 1915).  The definitive studies were carried out by
Reagan, who demonstrated that chick embryos that had their headfolds dissected
from the yolk sac, at a period before an extraembryonic invasion of vascular cells
could occur, still formed blood vessels.
Unlike extraembryonic vasculogenesis, the formation of intraembryonic
angioblasts does not originate in blood islands.  In fact, with the exception of
aortic endothelial cells in avian embryos, early vasculogenesis does not appear to
be connected with hematopoiesis at all (Dieterlen-Lièvre and Martin, 1981; Olah
et al., 1988; Pardanaud et al., 1989).  Due to the lack of blood cells in the vessels
and the absence of readily recognizable histological features for intraembryonic
angioblasts, the early events of vasculogenesis were virtually impossible to
describe using classical embryology techniques.  By the time blood vessels could
be resolved by ink injections (Evans, 1909), they had already undergone a
substantial amount of development.  The advent of electron microscopy
techniques allowed for additional characterization of vascular assembly (Hirakow
and Hiruma, 1983; Meier, 1980) but, once again, the absence of molecular
markers continued to present difficulties for the identification of angioblasts prior
to vascular assembly.  Understanding of the early events of vasculogenesis took a
great leap forward with the identification of QH-1, a monoclonal antibody which
specifically recognizes quail endothelial cells (Pardanaud et al., 1987).  The
enormous advantage of QH-1 was that it allowed accurate identification of free
intraembryonic angioblasts prior to vascular assembly and therefore facilitated the
first detailed studies of early vasculogenesis.  These studies indicated that the first
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angioblasts in the embryo proper can be detected at approximately the one somite
stage in bilateral sites near the headfolds corresponding to future endocardium,
and slightly later in the lateral edges of the anterior intestinal portal and in the
area ventral to the somites (Pardanaud et al., 1987; Coffin and Poole, 1988; Sugi
and Markwald, 1996).  The most prominent concentrations of angioblasts will
form the paired dorsal aortae.  These angioblasts apparently arose in situ and
therefore the formation of the dorsal aortae in chick is an example of type I
vasculogenesis (Poole and Coffin, 1991), however, examples presented below
will show that the situation is different in some other embryo systems.  Additional
aggregations of angioblasts mark the future sites of the large vessels, including
the vitelline veins, the cardinal veins, the ventral aortae and the aortic arches (Fig.
1) (Pardanaud et al., 1987; Coffin and Poole, 1988).  Finally, individual
angioblasts are observed throughout the splanchnic mesoderm.  These will later
assemble into the primary vascular plexus supplementary to the large vessels, and
may possibly contribute to large vessel formation through the process of fusion
(Drake and Little, 1998).  As development proceeds, the primary vessels lumenate
(form vascular tubes) and soon after the commencement of heart contractions,
blood begins flowing.
As mentioned previously, angioblasts arise exclusively within mesodermal
tissue (See Inductive signaling and specification of angioblasts, below.)
Vascularization of tissue and organs of non-mesodermal origin (e.g. the brain and
the visceral organs) proceeds via invasion of these tissues by blood vessels arising
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from the adjacent mesodermal structures by angiogenesis.  It is important to note
that not all mesodermal tissues are vascularized by the process of vasculogenesis
even though almost all mesoderm does have the potential to form angioblasts.
Vasculogenesis is predominantly limited to ventrolateral mesoderm and does not
occur in dorsoanterior mesoderm, probably due to an inhibitory effect of ectoderm
(Augustine, 1981; Pardanaud and Dieterlen-Lièvre, 1999).  In the avian embryo,
vascular development proceeds in an anterior to posterior wave through the
embryo.  Therefore, the anterior regions of the paired dorsal aortae may already
be clearly defined, lumenated vessels, while the posterior extremities of the same
presumptive vessels are merely concentrations of free angioblasts (Drake and
Little, 1998).
1.2.4.  Other vertebrate embryos
While the embryology of vascular formation is best described for the
chick, several other organisms have become increasingly useful for studying
vascular development, primarily due to the advent of molecular markers for
angioblasts and the increased accessibility of these systems to observation and/or
genetic manipulations.  Vasculogenesis in mouse embryos has been described
using antibody methods (Coffin et al., 1991) and more recently using confocal
microscopy techniques by Drake and Fleming (2000).  These studies show that
extraembryonic vascular cell development is initially detected at E6.5 in the
ectoplacental cone of the yolk (extraembryonic mesoderm).  Intraembryonic
vasculogenesis commences in E7.3 embryos at positions in the mesoderm which
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later give rise to the endocardium.  By E7.8, endothelial cells have undergone a
considerable degree of proliferation and are also present laterally along the flank
of the developing embryo in the region where the paired dorsal aortae will form.
These dorsal aortae have fused by E8.5 forming a single dorsal aorta located at
the midline of the embryo (Drake and Fleming, 2000).
Comparative studies of embryos from different species have revealed
some intriguing differences in the temporal sequence of events leading to blood
vessel development and have also revealed additional mechanisms involved in
determining the architecture of the original vascular plexus.  The development of
Xenopus and zebrafish embryos are especially interesting because they do not
generate extraembryonic vessels and therefore only undergo intraembryonic
vasculogenesis.  In Xenopus, angioblasts are first observed in early tailbud
embryos, in areas corresponding to the future endocardium and also some head
mesenchyme.  Slightly later, lines of angioblasts can be observed on each side of
the embryo, adjacent and immediately ventral to the somites, where the posterior
cardinal veins will later form (Cleaver et al., 1997).  A broadly similar pattern of
vasculogenesis is observed in zebrafish embryos (Fouquet et al., 1997).
Unlike avian embryos, where the paired dorsal aortae are the first major
axial vessels to develop, the first clearly defined axial vessels in Xenopus are the
paired posterior cardinal veins.  The angioblasts that assemble to form these
vessels apparently arise in situ  (an example of type I vasculogenesis).  In
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contrast, the dorsal aorta forms from angioblasts that migrate medially, from the
pool of precursors in the posterior cardinal vein region, to the midline of the
embryo.  These cells then assemble into a single dorsal aorta (Cleaver and Krieg,
1998).  This assembly, following migration, is an example of type 2
vasculogenesis.  At the anatomical level, this migration appears to be mediated by
the hypochord, a transient structure in Amphibian and fish embryos, which
secretes high levels of the small, diffusible form of VEGF (see below) (Cleaver
and Krieg, 1998).  A similar situation is thought to take place in zebrafish, where
mutants that lack a hypochord fail to form a dorsal aorta.  Both the floating head
(flh) and no tail (ntl) mutants lack a hypochord as a secondary consequence of
defects in notochord formation and also fail to form a dorsal aorta (Fouquet et al.,
1997; Sumoy et al., 1997; Weinstein, 1999).  It is important to note that no
hypochord is present in amniotes such as chicken or mice and therefore other
sources of VEGF secretion may pattern dorsal aorta development in these
organisms.  Indeed, the developing mouse embryo contains high levels of VEGF
in the endoderm prior to dorsal aortae formation, suggesting that the endoderm
may fulfill the role of the hypochord in mice (Miquerol et al., 1999).  Perhaps the
major significance of these studies is the observation that angioblasts can migrate
large distances within the embryo, in response to growth factor signaling.
Although such migrating angioblasts had previously been observed in avian
embryos (Noden, 1989; Christ et al., 1990; Wilms et al., 1991; Wilting et al.,
1995), their significance for formation of the primary vascular network was
unclear.  Overall, it appears that angioblast migration in response to growth factor
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signaling is playing a major part in determining the location and arrangement of
the major vessels in all vertebrate embryos.
1.2.5.  Inductive signaling and specification of angioblasts
Both intraembryonic and extraembryonic angioblasts are mesodermal in
origin (Van der Stricht, 1895; Rückert and Mollier, 1906; Dantschakoff, 1908).
The subsequent cell signaling and tissue patterning events that occur during
gastrulation are not required for angioblasts to form (Azar and Eyal-Giladi, 1979;
Christ et al., 1991; Krah et al., 1994; von Kirschhofer et al., 1994).  By using
chick-quail grafting techniques, it has been possible to learn a considerable
amount about the angioblastic potential of different types of mesoderm.  All
embryonic mesoderm with the exception of prechordal mesoderm has at least
some capacity to generate angioblasts (Noden, 1989; Wilms et al., 1991; Wilting
et al., 1995).  Thus the actual development of angioblasts and blood vessels
appears to be context dependent.  In other words, the tissue environment in and
around a specific region of mesoderm is responsible for regulating vascular
endothelial cell specification and commitment (Pardanaud et al., 1989; Pardanaud
and Dieterlen-Lièvre, 1999; Cox and Poole, 2000).
Despite the critical importance of angioblasts for formation of the
embryonic vasculature, the precise origins of these cells remain obscure.
Classical embryologists noticed that angioblasts in the extraembryonic blood
islands and also in the earliest intraembryonic blood vessels arise in close
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proximity to endoderm.  This observation raised the possibility that an inductive
signaling process between the endoderm and the mesoderm was required for
angioblast specification.  The hypothesis gained support from a number of
different studies carried out using the avian embryo (Wilt, 1965; Miura and Wilt,
1969; Pardanaud et al., 1989).  For example, in chick tissue culture experiments,
when specific portions of the area vasculosa that form the extraembryonic blood
islands were separated into the mesectodermal and endodermal components, the
mesectodermal component never contained endothelial cells (Wilt, 1965).
Endothelial cell differentiation could be restored if the mesectoderm was
recombined with endoderm.  This suggests that an endodermally derived
inductive signal is necessary for endothelial cell formation, at least in the context
of blood island formation.  In a follow-up study, Miura and Wilt (1969)
confirmed the inductive role of endoderm, but found a slight amount of blood
formation in isolated mesectoderm, which they suggested could be due to factors
in the culture medium.  Pardanaud et al (1989) proposed that close association
with the endoderm is necessary for vasculogenesis based on the close physical
proximity of vasculogenic mesoderm to endoderm.  It is noteworthy however, that
no experiments were carried out to explicitly address this proposition.
While these studies implied that endoderm is required for blood island
formation, in the absence of molecular markers it was not possible to identify
individual angioblasts prior to blood vessel formation.  Even so, the requirement
for endoderm during vascular cell development is widely stated in the literature
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and has assumed the status of dogma.  Recently however, the essential role of
endoderm in the specification of angioblasts has been re-evaluated.  For example,
it has been shown that mouse embryoid bodies lacking the transcription factor,
GATA-4, fail to form extraembryonic endoderm.  In the absence of endoderm,
these embryoid bodies are unable to form blood islands, in agreement with the
endoderm induction model.  However, use of molecular markers indicated that
formation of endothelial cells was not affected in these embryos (Bielinska et al.,
1996).  This result implies that the primary role of endoderm is in inducing
formation of blood island, and not in specifying vascular endothelial cells.
Similar results were obtained embryologically by Palis et al (1995), who showed
that murine yolk sac explants containing extraembryonic mesoderm but not
endoderm, still developed endothelial cells, but lacked organized vessels.  While
these studies hinted that endoderm might not be necessary for angioblast
specification, the issue was definitively addressed in a recent study by Vokes and
Krieg (2002a).  In a series of experiments, we demonstrated that both Xenopus
and avian embryos contain angioblasts in the complete absence of endoderm.  At
present therefore, the role of inductive interactions in the specification of
angioblasts is uncertain, but it appears that it must be limited to interactions that
occur exclusively within the mesoderm.
1.2.6.  The Theory of the Hemangioblast
The observation that blood islands are comprised of endothelial cells
surrounding primitive erythrocytes led early investigators to postulate that
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endothelial cells and blood cells were derived from the same lineage (His, 1868;
Sabin, 1920).  The putative precursor cell, which would possess properties of both
endothelial and hematopoietic lineages, was termed the hemangioblast (Murray,
1932; Wagner, 1980).  Despite the fact that this theory is now over a century old,
the existence of the hemangioblast, in vivo, remains controversial.  The
proposition however, has gained increased support from certain molecular
genetics experiments and it now seems likely that at least some blood and
endothelial cells are derived from the same initial population, although the
common precursor cell has never been definitively detected within the embryo.
Perhaps the best evidence for the existence of the hemangioblast comes
from studies of avian embryos.  During development of the avian embryo, the
endothelial cells that comprise the dorsal aorta arise from two distinct populations
of mesodermal cells.  Angioblasts derived from the splanchnic mesoderm make
up the floor of the dorsal aorta, while angioblasts from the somatic mesoderm
form the roof and walls of the aorta.  The endothelial cells in the floor of the
dorsal aorta have been shown, by lineage tracing, to have the potential to give rise
to definitive hemopoietic cells (Jaffredo et al., 1998).  These results clearly show
a close relationship between the endothelial cell and blood lineages, but stop short
of definitively proving the existence of the hemangioblast in vivo.  Additional
support for the hemangioblast comes from studies of the VEGF receptor,
VEGFR2 (see below).  Mice genetically ablated for VEGFR2 fail to form either
extraembryonic blood islands or mature endothelial cells (Shalaby et al., 1995)
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suggesting that the two lineages are closely related.  Intraembryonic development
of blood cells could not be assayed because the embyros die before definitive
development of the lineage.  Despite this phenotype, embryos expressing the
sensitive β-galactosidase reporter protein under control of the VEGFR2 promoter,
never showed staining in the blood cells in the blood islands, indicating that
expression levels are extremely low or non-existent (Shalaby et al., 1995).
Independent studies using antibodies have failed to detect VEGFR2 protein in the
hematopoietic interior of blood islands or in intraembryonic hematopoietic
regions (Drake and Fleming, 2000).  Together, these studies suggest that, if
VEGFR2 is indeed expressed in hemangioblasts, its expression must very quickly
be lost from committed hematopoietic cells.  The situation is further complicated
by the observation that VEGFR2 -/- embryonic stem cells, in embryoid bodies,
have the ability to differentiate into blood cell precursors, demonstrating that
VEGFR2 is not strictly necessary for hematopoiesis (Shalaby et al., 1997).  The
same cells are unable to contribute to vascular structures.  One interpretation of
these results is that VEGFR2 is necessary for placing these cells in the correct
environment to develop into hematopoietic stem cells, but is not strictly required
for the hematopoietic pathway.
In addition to VEGFR-2, several other molecular markers are shared
between endothelial and hematopoietic lines.  These include the transcription
factor SCL/Tal (Kallianpur et al., 1994; Drake et al., 1997; Liao et al., 1998;
Drake and Fleming, 2000), the cytokine TGF-β1 (Akhurst et al., 1990), the MB1
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antigen (Péault et al., 1983; Labastie et al., 1986) and the von Willebrand factor
(Jaffe et al., 1973).  Moreover, in avian embryos, there are two lineages that
express the antibody QH-1.  The first is the splanchnopleural mesoderm, which
contributes to both endothelial and hematopoietic cell lineages.  The second is the
somitic mesoderm which contributes only endothelial cells.  This suggests that
there is a sub-population of QH-1 positive cells in the lateral plate that have
hemangioblastic potential (Pardanaud et al., 1996).  Likewise, the zebrafish
mutation cloche (clo) has severe defects in both endothelial and hematopoietic
cell formation and normal embryonic expression of VEGFR-2 is severely
reduced.  Therefore cloche activity must lie very early in the pathway leading to
blood cells and endothelial cells, perhaps within the hemangioblast itself (Stainier
et al., 1995; Fouquet et al., 1997; Liao et al., 1997; Liao, et al., 1998; Thompson
et al., 1998; Parker and Stainier, 1999).
Further evidence for the existence of the hemangioblast comes from
studies of cells in culture.  Using embryoid bodies as a source, a murine cell line
(BLast Colony Forming Cells or BL-CFCs) has been derived that expresses
markers of both endothelial and hematopoietic lineages (Choi et al., 1998; Faloon
et al., 2000).  This cell line can be experimentally manipulated, in vitro, to
develop along either or both pathways and therefore possesses the properties
predicted for the hemangioblast.  Nonetheless, such a cell has never been
observed in vivo, and its elusiveness suggests that hemangioblast cells must be a
very transient population.
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1.3.  MOLECULAR BIOLOGY OF VASCULAR DEVELOPMENT
1.3.1  Differentiation of the Vascular Endothelial Cell Lineage
1.3.1.1.  Vascular Endothelial Growth Factor (VEGF) and its Receptors
Vascular Endothelial Growth Factor-A (VEGF-A, hereafter referred to as
VEGF) is a secreted dimeric protein that plays a critical role in vascular
endothelial cell differentiation and proliferation.  Other VEGF family proteins are
also expressed in the developing embryo, but, with the possible exception of
VEGF-C and its receptor VEGFR3/Flt-4, these do not appear to play a significant
role in blood vessel development.  For reviews dealing with other VEGFs (VEGF
B-E) and the VEGF related molecule Placenta Growth Factor (PlGF), see
Eriksson and Alitalo (1999) and Persico et al. (1999).  The expression of VEGF in
mice has recently been examined with great sensitivity by genetically inserting
the β-galactosidase reporter module into an untranslated region of VEGF mRNA
(Miquerol et al., 1999).  This study resolved VEGF expression at the cellular
level, thereby providing an extremely accurate description of the many domains
of VEGF expression in the developing mammalian embryo.  VEGF is a powerful
mitogen specific for vascular endothelial cells, and also has an important function
in mediating the chemotaxis of angioblasts.  Postnatally, VEGF plays critical
roles in endothelial cell survival (Gerber et al., 1999), tumor angiogenesis (Holash
et al., 1999) and vascular permeability (Keck et al., 1989).  The VEGF ligand is
bound by two high affinity receptors, VEGFR2 (Flk-1/KDR) and VEGFR1 (Flt-
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1), both of which belong to the tyrosine kinase receptor family.  VEGFR1 and
VEGFR2 are expressed exclusively in vascular endothelial cells, and VEGFR2
represents the earliest known specific marker of endothelial cells.
1.3.1.2.  Isoforms of the VEGF protein
Depending on the specific organism, as many as five different isoforms of
VEGF protein are known to be produced.  These different proteins are generated
by alternative splicing of the primary transcript from the single VEGF gene
(Leung et al., 1989).  In humans, the different forms of VEGF protein are called
VEGF121, VEGF145, VEGF165, VEGF189 and VEGF206, where the number refers to
the length of the protein in amino acids.  The precise lengths of the equivalent
protein isoforms are slightly different in other organisms, but unless specifically
stated otherwise, we will use the human numbering to identify the different
isoforms.  In all species examined, VEGF121, VEGF165 and VEGF189 are the most
abundant variants in most tissues.  Relative to VEGF121, VEGF165 has a 44 amino
acid domain inserted close to the C-terminus of the protein and VEGF189 contains
an additional 24 amino acids, also close to the C-terminus.  The presence of these
additional protein domains has been shown to alter the biochemical properties of
the different VEGF isoforms when assayed in cell culture systems.  For example,
VEGF121 is freely diffusible upon cellular secretion, while the medium and large
forms have increasing affinities for heparin sulfate, an important component of
the extracellular matrix, ECM (Houck et al., 1992). The heparin sulfate
proteoglycan, glypican-1, has been shown to bind VEGF165 and presumably binds
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VEGF189 even more efficiently (Gengrinovitch et al., 1999).  In transfected cell
cultures, both VEGF121 and VEGF165 are present in conditioned media, while the
large form is apparently bound to the cell surface or matrix (Houck et al., 1991).
The presence of VEGF165 in conditioned media is indicative of its intermediate
affinity for ECM components.
In vitro studies suggest that VEGF165 is approximately 100-fold more
effective at stimulating mitosis than VEGF121 (Keyt et al., 1996).  Experiments
using quail embryos have shown that administration of VEGF121 to the
chorioallantoic membrane causes a fourfold increase in endothelial cell number
relative to controls with no added VEGF, although the degree of proliferation was
not directly compared with that obtained by administration of VEGF165 (Wilting et
al., 1996).  For technical reasons, it is difficult to assess the mitogenic potency of
VEGF189 since it is completely bound to the ECM and therefore is not present in
conditioned media.  However, within the developing embryo, this property may
confer an important regulatory control by limiting the spatial distribution of
VEGF189.  Park et al (1993) cultured endothelial cells on ECM that had been
conditioned with different VEGF isoforms, and found that, as expected due to its
diffusion properties, VEGF121 was not present in ECM, whereas VEGF189 and
VEGF206 induced proliferation of endothelial cells at rates that were three to four
times higher than controls.  ECM conditioned with VEGF165 induced proliferation
at rates that were approximately twice that of controls.  This difference in activity
is most likely due to the reduced affinity of ECM for VEGF165 compared to the
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larger isoforms rather than a reduction in bioactivity.  In fact, the amount of
VEGF165 present in the ECM was undetectable, indicating that very low amounts
of VEGF165 are sufficient to induce endothelial proliferation.  Additional
experiments demonstrate that VEGF isoforms that are bound to ECM can be
proteolytically cleaved to yield biologically active molecules that are free to move
into the conditioned medium (Keyt et al., 1996).  Although this effect was
demonstrated in vitro, it seems likely that such mechanisms will also exist in the
developing embryo.
In addition to its role as a mitogen, an increasing body of evidence
demonstrates that VEGF acts as a chemoattractant for endothelial cells.  This was
first demonstrated by showing that endothelial cells in culture migrate towards a
source of VEGF165 (Waltenberger et al., 1994).  This action was posited, although
not demonstrated, to occur during vascular development in the mouse embryo by
Dumont et al (1995).  More recent experimental evidence indicates that VEGF165,
specifically expressed in the lens of transgenic mice, also mediates vascular
endothelial cell chemotaxis (Ash and Overbeek, 2000).  When tissue ectopically
expressing VEGF121 is transplanted into the Xenopus embryo, it causes in vivo
endothelial cell migration over distances of hundreds of microns (Cleaver and
Krieg, 1998).  While the chemoattractant properties of VEGF165 and VEGF189
have not been directly compared to VEGF121 in vivo, they would be predicted to
be less active than VEGF121, due to their limited diffusion properties.
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1.3.1.3.  Genetic Studies of VEGF
VEGF activity in the early embryo is primarily mediated though the high
affinity receptor VEGFR2, which is responsible for transducing the mitogenic and
chemoattractant signaling properties of VEGF.  In most cases, the embryonic
expression domains of VEGFR2 and VEGF are complementary, strongly
suggesting a paracrine signaling pathway for VEGF between adjacent tissues
(Breier et al., 1992; Yamaguchi et al., 1993; Dumont et al., 1995; Flamme et al.,
1995a; Cleaver et al., 1997; Fouquet et al., 1997; Liang et al., 1998).
Gene ablation experiments in mice, and overexpression studies in mouse,
frog and avian systems demonstrate the essential function of VEGF and its
receptors during early vasculogenesis.  Remarkably, the loss of even one copy of
the VEGF gene is embryonic lethal in the mouse embryo, demonstrating a
striking level of dosage sensitivity (Carmeliet et al., 1996; Ferrara et al., 1996).
Heterozygous (VEGF +/-) embryos died at approximately E11 from severe
vascular defects, primarily disorganized and leaky blood vessels.  For example,
the dorsal aorta was poorly developed and much smaller than that observed in
wild-type embryos.  The defects are much more extreme in embryos totally
lacking VEGF function.  These embryos die at approximately the same stage as
heterozygotes, but contain an extremely low number of vascular endothelial cells
and exhibit a complete absence of any organized vascular structures (Carmeliet et
al., 1996).  As suggested by the lethality of the heterozygous VEGF +/- mouse,
expression levels of VEGF are extremely finely regulated by the action of a
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number of different cellular mechanisms.  In addition to transcriptional regulation,
VEGF activity is modulated at the level of translation, via the presence of two
distinct internal ribosome entry sites (IRES) (Akiri et al., 1998; Huez et al., 1998;
Stein et al., 1998).  Although primarily investigated in the context of low oxygen
conditions (hypoxia), VEGF is also regulated at the level of mRNA stability
(Ikeda et al., 1995; Liu et al., 1995).  It is likely that a combination of all these
mechanisms acts to regulate the levels of VEGF activity during embryonic
vasculogenesis.
Whereas the gene ablation studies show that a reduction in VEGF levels is
embryonic lethal due to failure of vascular formation, overexpression of VEGF in
Xenopus and avian embryos causes ectopic blood vessel development in normally
avascular regions, as well as hypervascularization and fusion of blood vessels
(Drake and Little, 1995; Flamme et al., 1995b; Cleaver et al., 1997; Drake and
Little, 1999).  Additional genetic experiments in mouse have addressed the
developmental function of the different VEGF isoforms.  Embryos lacking the
exons encoding the VEGF165 and VEGF189 isoforms, and consequently expressing
predominantly VEGF121, are viable throughout embryonic development, but die
postnatally (by approximately P14) due to either internal bleeding or multiple
cardiac problems (Carmeliet et al., 1999a).  Therefore, despite the apparent
differences in mitotic activity and biochemical properties of the different VEGF
isoforms revealed in cell culture studies (see above) this experiment demonstrates
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that the VEGF121 isoform alone is sufficient to regulate the great majority of
cellular and morphological events that occur during early vascular development.
1.3.1.4.  Genetic Studies of VEGF receptors
The phenotype of embryos lacking function of the high affinity VEGF
receptor, VEGFR2, is even more severe than that of the VEGF knockout and
indicates an absolute requirement for VEGFR2 in endothelial development.
Embryos die between E8.5 and E9.5, lacking yolk sac blood islands and all
intraembryonic vessels.  The embryos fail to form endothelial cells and show a
complete absence of blood cells.  This latter defect suggests that VEGFR2 is
essential for some early aspect of hematopoietic development (Shalaby et al.,
1995).  As mentioned above, VEGF-/- embryos die at about E11, approximately
two days later than embryos lacking VEGFR2 function.  Although both are
embryonic lethal, the non-equivalence of the VEGF-/- and VEGFR2-/- phenotypes
suggests that a low level of receptor binding, presumably by other members of the
VEGF family, is able to partially rescue endothelial cell development in the
embryos lacking VEGF-A activity.  Additional experiments using chimeric
embryos demonstrated that VEGFR2-/- cells are never present in the vascular
endothelium, indicating a cell autonomous requirement for VEGFR2 (Shalaby et
al., 1997).
Genetic ablation of the other high affinity VEGF receptor, VEGFR1, is
also embryonic lethal, in this case due to severely malformed vascular channels
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(Fong et al., 1995).  In these VEGFR1-/- embryos, an excessive number of
endothelial cells were present, leading to the presence of endothelial cells in the
interior as well as the periphery of extraembryonic blood islands.  Within the
embryo itself, endothelial cells are present inside abnormally enlarged vascular
structures.  More recent work demonstrates that an alteration in cell fate
determination in VEGFR1-/- embryos causes an increase in the number of both
vascular endothelial cells and blood cells, relative to wildtype (Fong et al., 1999).
This increased density of endothelial cells is responsible for the defects in
vascular assembly, since VEGFR1-/- endothelial cells are capable of forming
normal endothelial channels when they are present in chimeric embryos.  As an
interesting aside, even though VEGFR1 has a tyrosine kinase domain, ablation of
this domain does not effect normal vascular development, providing that the
ligand-binding domain is intact (Hiratsuka, et al 1998).  Based on these
observations, it is proposed that the principal role of VEGFR1 in vasculogenesis
is to sequester excess VEGF ligand, thereby regulating endothelial proliferation
(Fong et al., 1999).
In addition to the two tyrosine kinase receptors, VEGFR2 and VEGFR1, it
was recently discovered that neuropilin-1 can also act as a receptor for VEGF, in
particular the VEGF165 isoform (Soker et al., 1998).  This observation was
unexpected, since neuropilin-1 had previously been characterized as a receptor
that mediates semaphorin signaling during axonal pathfinding (He and Tessier-
Lavigne, 1997).  When neuropilin-1 and VEGFR2 are co-expressed in the same
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cell, addition of VEGF165, but not VEGF121, causes an approximately 3-fold
increase in migration of endothelial cells (Soker et al., 1998).  Recently,
neuropilin-1 was also shown to bind VEGF165 when co-expressed with VEGFR1
(Fuh et al., 2000).  A significant role for neuropilin in embryonic vascular
development is demonstrated by mouse gene ablation experiments which show
that mice lacking neuropilin-1 exhibit both axonal defects and cardiovascular
defects, including problems with formation of the dorsal aorta and the
extraembryonic blood vessels (Kawasaki et al., 1999).  An additional neuropilin
receptor, neuropilin-2, also binds VEGF165, suggesting that it too will play a role
in vasculogenesis (Gluzman-Poltorak et al., 2000).
1.3.2 Vascular tubulogenesis
Vascular tubulogenesis, the process by which angioblasts coalesce into
vascular cords and then form a continuous, tubular network is not well
understood.  Nonetheless, it is clear that this is a highly coordinated process
within the developing embryo.  In avian embryos, for example, the entire primary
vascular network assembles over a period of less than 8 hours, between the 4-
somite and 8-somite stages of development.  During this process, angioblasts
assemble into solid clusters of cells that then form tubes (Hirakow and Hiruma,
1983; Coffin and Poole, 1988).   The initial formation of a vascular lumen occurs
when a ‘slit-like space’ opens up between two angioblasts.  These spaces enlarge,
combining with other such spaces to form a hollow endothelial tube (Houser et
al., 1961).  At least in some cases, lumen formation precedes the formation of a
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continuous endothelial network (Hirakow and Hiruma, 1983; Drake and
Jacobson, 1988).  In order to form a lumen, angioblasts must presumably acquire
polarity, containing apical and basal surfaces.  Study of this process has been
precluded by the lack of known cell polarity markers in angioblasts.  As might be
expected, cell adhesion molecules and extracellular matrix components are
thought to play pivotal roles in this process.
Amongst the factors known to be essential for vascular assembly is the
extracellular matrix (ECM).  ECM is a complex mixture of proteins and
glycoproteins, and a broad range of different experimental approaches have
demonstrated that ECM proteins, including laminin, integrins, collagen and
fibronectin serve regulatory functions during blood vessel assembly.  In the case
of collagen, cell culture studies have shown that endothelial cells which are able
to synthesize type 1 collagen will spontaneously form endothelial cords, whereas
endothelial cells that do not express type 1 collagen will not form these
aggregates (Vernon et al., 1995).  It has been proposed that angioblasts
associating with ECM fibers are capable of coalescing into aggregates, through
forces exerted on the ECM.  This establishes the rough boundaries of the vascular
network, which subsequently forms a continuous tissue layer, either by protrusive
cellular extensions or by recruiting additional angioblasts (Drake and Little,
1998).
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One family of ECM proteins implicated in vascular assembly is the
integrins, a large group of related glycoproteins that effect cell adhesion by
binding to an array of extracellular matrix components (for general reviews see
Yamada and Miyamoto, 1995; Hynes and Bader, 1997).  Much attention has been
focused on the integrin αvβ3 dimer, expression of which is upregulated during both
vascular assembly and angiogenesis (Brooks et al., 1994; Drake et al., 1995).  A
neutralizing antibody to this integrin specifically inhibits the attachment of
endothelial cells to fibrinogen, vitronectin and the von Willebrand factor
(Cheresh, 1987), all of which are expressed embryonically and may be involved
in embryonic vascular adhesion.  Indeed, the application of this monoclonal
antibody to avian embryos disrupted lumen formation, suggesting that the αvβ3
integrins play a direct role in mediating lumen formation (Drake et al., 1995).
Given this result, it was surprising that mice in which the αv gene had been
ablated, and therefore lacked all αv type integrins, developed a relatively normal
vascular system (Bader et al., 1998).  It remains possible that some additional
member of the integrin α family partially rescued αv function in the mutant mice,
but at present, the precise role that αvβ3 integrins play in lumen formation is
unclear.  It has also proven difficult to determine how other integrins, such as
those which bind fibronectin, are involved in vascular assembly because a
considerable amount of functional redundancy exists between integrin family
members.  One reasonably clear example, however is integrin α5, ablation of
which causes multiple development defects, including problems with vascular
assembly (Yang et al., 1993).  Efforts to analyze embryos lacking two different
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integrins has proved frustrating.  For example, mice lacking function of both the
αv and α5 integrin subunits die very early in development due to gastrulation
defects (Yang et al., 1999), thereby precluding an analysis of their vascular
phenotype.
In addition to structural proteins, regulatory molecules also play an
important role during vascular assembly.  The VEGF signaling pathway, which is
absolutely required for vascular cell development, is also involved in the correct
assembly of endothelial cells into lumenated vessels.  Mice lacking the VEGF
receptor, VEGFR1, develop abnormal vascular channels containing internalized
endothelial cells.  The phenotype is apparently due to an overproliferation of
endothelial cells caused by excess VEGF (Fong et al., 1995, 1999) (see above).
This suggests that one of the important steps in vessel formation is the down-
regulation of endothelial cell mitosis.  Indeed, when large amounts of excess
VEGF ligand are added to avian embryos, the results include both
hypervascularization and also abnormally large vascular lumens (Drake and
Little, 1995).  Conversely, insufficient VEGF activity results in the failure of
angioblasts to form endothelial tubes (Damert et al., 2002).
1.3.3.  Notch signaling
Until very recently, Notch signaling was thought to play a comparatively
minor role in vascular development, mainly in vascular remodeling.  Within the
last two years, however, the Notch signaling pathway has been suggested to play
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a pivotal role in determining whether an angioblast acquires an arterial or venous
fate.  Although all nascent endothelial tubes are superficially similar, they contain
genetic differences.  For example, the presence of ephrinB2 marks future arteries,
while EphB4 marks future veins in zebrafish (Lawson et al., 2001).  Zebrafish
embryos deficient in Notch signaling have a loss of artery-specific markers with a
concomitant gain in venous markers.  Furthermore, activated Notch signaling
results in the repression of venous markers (Lawson et al, 2001).  This data is
corroborated by a recent expression survey of Notch signaling components in
mice that indicates that Notch expression is limited to arterial vessels (Villa et al.,
2001). The genetic network involving Notch arterial specification is controversial.
One study in zebrafish argues that both Shh and VEGF lie downstream of Notch
in arterial specification (Lawson et al., 2002).  However, this data is hard to
reconcile with an overwhelming amount of genetic data indicating that VEGF is
essential for the development of all blood vessels.
Gene ablation experiments in mice have also demonstrated a requirement
for Notch signaling in vascular development.  Mice deficient in Notch1 exhibit
defects in vascular assembly and vascular remodeling (Swiatek et al., 1994).
While the Notch4 knockout is completely viable (Krebs et al., 2000), embryos
that are homozygous double mutants for Notch4 and Notch1 show a more severe
vascular phenotype than Notch1 mutants alone, suggesting that the two receptors
play partially overlapping roles during vascular remodeling (Krebs et al., 2000).
Additionally, the expression of a constitutively active Notch4 protein in
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developing endothelial cells results in lethality by E10.  While the large vessels of
the embryo initially form, the mice have defects associated with vascular
patterning and remodeling (Uyttendaele et al., 2001).  Further evidence for the
role of the Notch signaling pathway in blood vessel development is provided by
experiments showing defects in the cranial vasculature in mice embryos deficient
in Jagged 1, a gene encoding a Notch ligand (Xue et al., 1999).  Overall, these
genetic studies suggest that Notch is involved in vascular remodeling and
angiogenesis.  However, none of these experiments addressed the role of Notch
signaling in arterial-venous specification.  In the future, it will be interesting to
examine whether the knockout phenotypes are caused by erroneous venous
specification.
1.3.4.  The Ephrin signaling pathway
The Eph/ephrins constitute a large family of tyrosine kinase receptors and
their cognate ligands.  The terminology for this family of molecules is quite
confusing, but in all cases the name of the ligand, ephrin, commences with a
lower case letter, while the name of the receptor, Ephrin, commences with a
capital and is usually abbreviated to Eph.  Unlike many ligand-receptor
interactions, ephrin ligands must remain cellularly bound to elicit a response.
Thus, for signaling to occur, the ephrin ligand must be present on the surface of a
cell juxtaposed with a cell containing an Ephrin receptor.  To date, at least 14
different receptors and 8 ligands comprising two subfamilies have been identified,
making Ephrins the largest known family of receptor tyrosine kinases (Van der
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Geer et al., 1994).  Because Ephrin signaling can only take place at regions where
cells are contacting each other, the system potentially provide a very precise
mechanism for control of cellular boundaries.  Eph/ephrins have been implicated
in the guidance of axonal growth cones, segmentation of the somites and
rhombomeres, retinotectal patterning, and cellular migration (reviewed in Holder
and Klein, 1999).  In addition, Ephrin signaling plays an essential role in early
vascular development.
The Ephrin receptors and their ligands are divided into two classes based
on the structure of their ephrin ligands.  Class A ephrins are attached to the
membrane via a glycosylphosphatidylinositol linkage, while class B ephrins are
transmembrane proteins.  As a general rule, class A ephrins bind class A receptors
and class B ephrins bind class B receptors.  The only known exception to this
pattern of class-specific segregation is EphA4, which binds several ephrin B
ligands in addition to class A ephrins (Gale et al., 1996).  One of the unique
characteristics of Ephrin signaling is that it occurs bidirectionally.  For example,
binding of either ephrinB1 or ephrinB2 ligands to the EphB2 receptor not only
causes tyrosine phosphorylation of the receptor, but also of the cognate ligand
molecules (Holland et al., 1996).  Studies using zebrafish embryos show that
Ephrin receptors and their ligands restrict cell mixing and cell communication in
vivo and that bidirectional signaling is indeed important for this function
(Mellitzer et al., 1999).
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While previous experiments had demonstrated a role for ephrinA1 and
EphA2 in pathogenic angiogenesis (Pandey et al., 1995), the significance of
Ephrin signaling in embryonic vascular development was first revealed by gene
ablation studies in mouse.  Embryos lacking ephrinB2 function displayed a severe
vascular phenotype (Wang et al., 1998), including gross abnormalities in the
formation of the circulatory system as well as a decrease in the size of the heart
and reduced myocardial trabeculation.  The mutant embryos died by E11.  While
the primary vascular system developed relatively normally, there was an absence
of internal carotid arterial branches and the mice exhibited malformed capillary
beds in the head as well as vascular defects in the yolk sac.  A closer examination
of the normal expression pattern of ephrinB2 in the embryo revealed that
expression is restricted to those endothelial cells that will contribute to the future
arteries and that this arterial specific expression is present from the earliest stages
of vasculogenesis (Wang et al., 1998).  In addition, an Ephrin receptor, EphB4, is
expressed in a reciprocal pattern in the developing venous network.  This striking
pair of observations leads to the possibility that endothelial cells that are fated to
contribute to veins or arteries are genetically distinct from a very early
developmental stage.  Furthermore, these studies implicate ephrinB2/EphB4
signaling in establishment of the boundaries between the arterial and venous
networks of the embryo.
Subsequent studies show that the role of Ephrin signaling during vascular
development is more complicated than it first appears.  Other Ephrin signaling
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molecules are also found in developing blood vessels.  For example, ephrinB1 is
expressed at high levels in both arteries and veins, and EphB3 is expressed in
developing veins and aortic arches (Adams et al., 1999).  Another receptor,
EphB2 is present in the mesenchyme adjacent to the umbilical vein.  Furthermore,
ephrinB2, in addition to its previously described expression in arterial endothelial
cells, is also expressed in the mesenchyme adjacent to intersomitic vessels.  These
observations suggest that Ephrin signaling may also be involved in blood vessel
development at the interface between endothelial cells and the adjacent
mesenchyme.  Nonetheless, conditionally ablating ephrin B2 specifically in the
endothelium phenocopies the cardiovascular effects of the ephrin B2 knockout
(Gerety and Anderson, 2002).  A possible biological role for these additional
Ephrin receptors and ligands is suggested by in vitro studies which show that both
ephrinB1 and ephrinB2 are capable of inducing capillary sprouting (Adams et al.,
1999).  Further evidence is provided by the demonstration that embryonic
misexpression of either the ephrin B ligand, or a dominant negative EphB4
receptor, results in abnormal growth of intersomitic blood vessels (Helbling et al.,
2000; Oike et al., 2002).  Overall, it is clear that Ephrin signaling plays an
important role in delineating the vascular system, and the reciprocal expression of
EphB4 and ephrinB2 on veins and arteries respectively makes it tempting to
speculate that these molecules, at least, are involved in conferring an arterial or
venous fate.  In addition, other members of the Ephrin signaling family appear to
be involved in regulation of vascular sprouting and morphogenesis.
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1.3.5.  Hedgehog signaling
Very recent data has implicated hedgehog signaling in vascular
development.  All vertebrates express three hedgehog genes, which are
homologues of the single hedgehog (Hh) gene in Drosophila.  These genes are
Shh, Indian hedgehog (Ihh) and Desert hedgehog (Dhh).  These share similar
biochemical activities (Pathi et al., 2001), and they share a common set of signal
transduction molecules.  The hedgehog receptor Patched (Ptc), which is
upregulated in response to Shh does not directly mediate hedgehog signaling.
Rather, in the absence of a Hh ligand, Ptc represses signaling by indirectly
blocking the activity of Smoothened (smo), another transmembrane protein.  Hh
binding to Ptc relieves its inhibition on Smo, allowing it to activate downstream
targets in a manner that is still poorly understood (rev. in Ingham and McMahon,
2001).
In mice, embryoid bodies derived from ES cells lacking either the global
hedgehog transducer smoothened or Ihh initially express endothelial cells
markers, however they are unable to form blood islands (Byrd et al., 2002).
Furthermore, Indian hedgehog can activate ectopic vasculogenesis in prospective
neurectoderm (Dyer et al, 2001).  The in vivo implications for this particular data
are unclear, however, because angioblasts are still specified in smoothened
deficient embryoid bodies that lack all hedgehog signaling (Byrd et al., 2002).
Sonic hedgehog has also been implicated as an indirect angiogenic factor in
postnatal mice (Pola et al., 2001). Finally, zebrafish shh mutants, such as the
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sonic-you mutations, do not form vascular tubes in the trunk region of the
embryo, although angioblasts are still present (Brown et al., 2000).  One recent
study has suggested that in combination with VEGF, Shh acts upstream in the
specification of the dorsal aorta in zebrafish (Lawson et al., 2002).  Overall, these
studies suggest important, but undefined roles for hedgehog signaling in vascular
development.
1.3.6. VE-cadherin
The calcium mediated cell adhesion protein, VE-cadherin (also known as
cadherin-5) is endothelial specific (Lampugnani et al., 1992; Breier et al., 1996),
and gene ablation experiments indicate that VE-cadherin plays a vital role in
mediating vascular assembly.  Mouse embryos lacking VE-cadherin express many
endothelial markers, but these cells fail form patent vessels in the anterior portion
of the body, and the embryos die by E11.5 of severe vascular defects (Gory-Fauré
et al., 1999).  The defects are even more spectacular in the extraembryonic yolk
sac and in embryoid bodies of mutant embryos, which contain no organized
vascular pattern (Vittet et al., 1997; Gory-Fauré et al., 1999).  Taken together,
these results support the idea that VE-cadherin plays a pivotal role in vascular
assembly.  However, the persistence of primary blood vessels in the posterior
regions of the embryo suggests that other cell adhesion molecules must have
overlapping roles in vascular assembly.
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Characteristic of cadherin proteins, VE-cadherin consists of an
extracellular domain involved in cell adhesion and an intracellular component that
mediates intracellular signaling.  The importance of the intracellular domain is
underscored by studies of mice genetically manipulated to express only a
truncated form of VE-cadherin that lacks the signaling domain (but still maintains
cell adhesion).  In these mice, assembly of the initial vascular network was not
affected, however, the endothelial cells failed to respond to anti-apoptotic
signaling mediated by VEGF and mice died at E9.5 due to vascular insufficiency
caused by increased apoptosis (Carmeliet et al., 1999b).  This interesting link
between VEGF signaling and VE-cadherin may help to explain the increased size
of blood vessels lumens that resulted when VEGF was overexpressed in chick
embryos (Drake and Little, 1995) (see above).
1.3.7.  Angiogenesis and vascular remodeling
The preceding sections have primarily addressed the formation of the
primary vascular plexus from individual angioblasts.  After this initial assembly,
the vascular network becomes greatly elaborated during a series of events termed
vascular remodeling.  This term encompasses a variety of processes in which the
vascular system expands and acquires the vast heterogeneity seen in mature blood
vessels.  Examples of this diversity range from the dense microcapillary networks
in the developing lungs to the large vessels such as major veins and arteries that
carry blood throughout the embryo (Evans, 1909).  It is important to note that the
process of vascular remodeling greatly alters the topography of pre-existing blood
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vessels and these changes continue throughout development to accommodate the
changing needs of the embryo.  The alterations not only include the development
of new vessels but also the regression of existing vessels.  For example, loss of
blood vessels is particularly prominent in the aortic arch region of the embryo.
The six pairs of symmetrical vessels present at various stages of development
undergo a programmed series of ablations and regressions such that only the third,
fourth and sixth pairs ultimately contribute to the adult vasculature.  In addition to
remodeling of the overall vascular architecture, the blood vessels themselves
physiologically mature.  Initially the vessels consist only of a tube of endothelial
cells, but during subsequent development they acquire layers of vascular smooth
muscles cells (or similar cells known as pericytes around capillaries), connective
tissues such as collagen and elastin, and a basement membrane.  The blood
vessels also acquire the physiological properties characteristic of either veins or
arteries.
Angiogenesis is defined as the sprouting or splitting of blood vessels from
pre-existing blood vessels.  The sprouting and splitting processes are achieved by
two quite different and distinct mechanisms.  In the embryo, sprouting
angiogenesis  (Hertig, 1935; Clark and Clark, 1939; Ausprunk and Folkman,
1977) is responsible for formation of the intersomitic vessels, vascularization of
the developing brain, growth of blood vessels into developing limbs and
vascularization of numerous other embryonic tissues (Coffin and Poole, 1988;
Risau, 1997).  Embryonic sprouting angiogenesis consists of several phases
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(Fig.4A).  Initially, endothelial cells detach and migrate out from the pre-existing
endothelial tube, in response to an angiogenic stimulus.  The cells continue to
extend further from the original vessel as sprouting continues.  In blood vessels in
the mature organism this process is known to involve degradation of the basement
membrane or ECM surrounding the endothelial cells prior to cell outgrowth
(Hiraoka et al., 1998).  However, this is unlikely to be the case in early embryonic
angiogenesis, where the basement membranes and ECM are still developing
(Wagner, 1980; Wilting and Christ, 1996).  Endothelial cell migration is followed
by lumen formation, which originates from the parent vessel and proceeds in a
proximal to distal direction along the branch.  In addition, the sprouting process
involves endothelial cell proliferation, which also proceeds in a proximal to distal
pattern (Ausprunk and Folkman, 1977; Wilting and Christ, 1996).
The second major type of embryonic angiogenesis is called
intussusceptive growth, the final result of which is expansion of microcapillary
beds.  This type of angiogenesis was first characterized during scanning electron
microscope studies on the developing capillaries in rat lungs (Caduff et al., 1986;
Burri and Tarek, 1990).  Subsequent studies have shown that the intussesceptive
growth occurs during blood vessel development in the avian chorioallantoic
membrane, in addition to sprouting angiogenesis (Patan et al., 1993; Patan et al.,
1996).  The process of angiogenesis by intussusceptive growth has been divided
into four stages (Fig. 4B).  In the first phase, the opposite walls of a vessel come
into contact with each other, forming an ‘interendothelial bridge.’  In the second
 43
Figure 4.  The two major forms of angiogenesis.
 (A) Sprouting angiogenesis is the most common mechanism for generating new blood
vessels in the embryo.  Endothelial cells migrate away from the parent vessel, proliferate
and form a vascular branch.  (B) Intussusceptive angiogenesis is primarily a mechanism
for increasing the vascular density of capillary beds.  In this mechanism, the opposite
walls of a vessel come together and split the capillary into two portions to create a
transcapillary post of tissue (shown in the inset), resulting in a splitting of the parent
capillary.  The numbers indicate progressive increase in the size of the intussusceptive
split.
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phase, as endothelial cells reorganize, the capillary is actually divided into two
portions by formation of a transcapillary post of tissue (somewhat analogous to a
pillar separating the floor and ceiling).  During phases three and four, this post is
stabilized by the addition of pericytes and connective tissue and grows in length,
gradually splitting the capillary into two daughter vessels.  The final result is the
creation of two adjacent vessels from a single original capillary.  Problems with
the process of intussceptive growth have been implicated at the cause of defects in
the intraembryonic vascular network of tie-1 and tie-2 mutant mice (Patan, 1998)
(See Angiopoietin Signaling).
1.3.8 Angiopoietin Signaling
1.3.8.1.  Tie Receptors
Angiopoietins and their receptors Tie-1 and Tie-2 (Tek) comprise another
developmentally essential signaling system involved in vascular formation.
Unlike VEGF and its tyrosine kinase receptors that act early in vasculogenesis to
specify the initial pattern of the vascular plexus and endothelial sprouting and
proliferation, the angiopoietin system acts later, after the primary vascular plexus
has been established.  Both Tie receptors are tyrosine kinases.  The Tie-2 receptor
is bound either agonistically or antagonistically by angiopoietins, while currently,
no ligands for Tie-1 have been identified.  Analysis of the signaling pathway
downstream of the Tie receptors is an area of active investigation, but is beyond
the scope of this chapter (for a review see Partanen and Dumont, 1999).
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Gene ablation studies in mouse demonstrate that the Tie-2 receptor is
essential for vascular patterning and remodeling in the embryo.  Dumont et al
(1994) analyzed tie-2 deficient mice and discovered that, although initial vascular
development was normal, there was a dramatic decrease in endothelial cells as
development continued.  Day E8.5 embryos contained approximately 30% fewer
endothelial cells than wild type, with a 75% reduction in endothelial cell number
by E9.0.  The embryos exhibited massive vascular hemorrhaging from both the
embryonic and yolk sac vasculature.  For example, in E9.5 embryos, the dorsal
aorta is often collapsed and blood cells may be detected in the adjacent
mesenchyme.  The embryos also exhibited defects in heart development,
suggesting that Tie-2 function may be required for interactions between the
myocardial and endocardial cell layers.  No embryos survived beyond E9.5.
Function of the tie-2 gene was independently ablated by Sato et al (1995).  Some
intriguing differences were observed in the mutant phenotype.  In contrast to the
previous studies (Dumont et al., 1994) which reported that vascular development
was normal until E8.5, Sato et al (1995) observed distinct abnormalities in
vascular formation, primarily in the head and extraembryonic vasculature.  In
these regions the blood vessels were homogenous in size, rather than displaying
the full range of different blood vessel diameters.  Presumably, this effect is due
to problems with remodeling of the primary vascular plexus.  Subsequent studies
have revealed that Tie-2 deficient blood vessels lack associated smooth muscle
cells (Patan, 1998).  Significantly, these studies of the tie-2 mutant phenotype
have direct relevance to human disease.  Vascular dysmorphogenesis, a human
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vascular malformation caused by diminished or absent smooth muscle in some
vascular channels, is caused by a mutation in the kinase domain of Tie-2 (Vikkula
et al., 1996).
Mice lacking Tie-1 receptor function die between E13.5 and birth.  While
the embryos initially have a normal vascular pattern, they develop edema and
localized hemorrhaging, resulting from leaky endothelial cells (Puri et al.; 1995,
Sato et al., 1995).  These endothelial cells exhibit abnormally thin extensions,
suggesting that the leaky phenotype may result from excessive endothelial cell
stretching (Patan, 1998).  Chimeric studies indicate that mutant endothelial cells
are initially comparable to wild type cells in their ability to populate the
embryonic blood vessels.  However by E15.5, there is a strong bias against the
tie-1 mutant endothelial cells in regions such as the intestinal and midbrain
capillary plexi, which are primarily vascularized by intussusceptive angiogenesis
(Burri and Tarek, 1990; see section an Angiogenesis and vascular remodeling).
On the other hand, large blood vessels like the aorta, which is formed by
vasculogenesis, still contain an equal representation of mutant cells (Partanen et
al., 1996).  Because tie-1 mutant embryos actually display denser capillary plexi
than wildtype embryos, it has been proposed that the phenotype may be due to an
increase in intussusceptive angiogenic growth resulting from more elastic
endothelial cells (Patan, 1998).
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The fact that both Tie-1 and Tie-2 are present in vascular endothelial cells
suggests that they may play partially redundant functions. To address this
question, mice lacking activity of both the Tie-1 and Tie-2 receptors have been
generated (Puri et al., 1999).  These embryos survive at least until E9.5 and
possess an intact vascular system.  The overall phenotype of the double mutant
was quite similar to that of embryos mutant for tie-2 alone, although the double
mutants also exhibited somitic defects.  Chimeric analysis of early stage embryos
indicates a strong reduction in the contribution of mutant cells to the
endocardium, but not to other regions containing endothelial cells.  However, by
E15.5, mutant cells are excluded from virtually all of the vascular system.
Overall, the exclusion of vascular endothelial cells mutant for both Tie-1 and Tie-
2 occurs much earlier and is more comprehensive than that observed for cells
mutant for Tie-1 alone (see above).  Based on the genetic studies and also on
detailed histological analysis, it is proposed that the major function of the Tie-2
receptor is to mediate interactions between endothelial cells and the extracellular
matrix (Patan, 1998).  In contrast, the primary function of Tie-1 appears to
involve inhibition of endothelial cell stretching, an activity which may help to
explain the leaky cell phenotype seen in the knockout (Patan, 1998).
 1.3.8.2.  Angiopoietins
Angiopoietins are the ligands for the Tie receptors.  Angiopoietin-1 (Ang-
1), binds specifically to Tie-2, but not Tie-1 (Davis et al., 1996).  Ang-1 is
expressed in mice starting at E9.0, at which stage it is strongly expressed in the
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myocardium.  During later development, Ang-1 becomes prominently expressed
in the mesenchyme surrounding maturing blood vessels.  On the other hand, the
Ang-1 receptor, Tie-2 is expressed in the endocardium and in endothelial cells
themselves.  The ligand and the receptor therefore, exhibit approximately
complementary expression patterns suggesting a paracrine signaling pathway.
Unlike VEGF however, Ang-1 does not elicit a proliferative response in
endothelial cells (Davis et al., 1996).  Ablation studies of the Ang-1 gene in mice
strongly suggest that Ang-1 is the principal biological ligand for Tie-2 because the
mutant phenotype recapitulates most aspects of the Tie-2 knockout phenotype.
Notably, Ang-1 -/- embryos die by E12.5, apparently due to heart defects that
closely resemble those observed in the Tie-2 knockout.  Furthermore, Ang-1 -/-
embryos also display defects in both vascular branching and vessel size, strikingly
similar to those in the Tie-2 mutant.  These vessels lack closely associated
periendothelial cells (Suri et al., 1996).  Overall, the defects in embryos lacking
Ang-1 function are slightly less severe than the Tie-2 knockout, an observation
that may be explained by the presence of other angiopoietins which partially
compensate the vascular defects (see below).  In addition to the gene ablation
studies, transgene approaches have been used to overexpress Ang-1 in the skin of
mice, under control of the keratin-14 promoter.  The skin capillaries in these mice
were larger, more numerous and more highly branched than those of control
embryos (Suri et al., 1998), further supporting a role for Ang-1 signaling in
vascular remodeling.
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Like Ang-1, Angiopoietin-2 (Ang-2) is expressed throughout the
embryonic vasculature, although in this case the pattern appears to be more
punctate.  Ang-2 binds to Tie-2, but shows no affinity for the Tie-1 receptor.  In
contrast to Ang-1, despite the fact that Ang-2 binds to Tie-2, it does not induce
phosphorylation (Maisonpierre et al., 1997; Kim et al., 2000).  Additional
experiments show that an excess of Ang-2 is capable of blocking Tie-2
phosphorylation by Ang-1, implying that Ang-2 may act as a natural antagonist of
Tie-2 mediated signaling.  Transgenic mice have been generated in which Ang-2
is expressed under control of the Tie-2 promoter, thereby ensuring that Tie-2 and
Ang-2 are expressed in the same cells.  These animals died at E9.5-10.5 as the
result of vascular defects very similar to those observed in the Tie-2 knockout
(Maisonpierre et al., 1997).  This result clearly supports the hypothesis that the
normal function of Ang-2 is to antagonize Tie-2 signaling.
Recently, several additional angiopoietin or angiopoietin related molecules
have been isolated (Kim et al., 1999a; Kim et al., 1999b; Nishimura et al., 1999;
Valenzuela et al., 1999).  Of these molecules, human Ang-4 has been shown to
bind and activate the Tie-2 receptor, while mouse Ang-3 binds to Tie-2 but acts as
an antagonist.  Surprisingly, none of these new angiopoietins are capable of
binding Tie-1.  It will be necessary to further characterize the new angiopoietins,
both biochemically and at the level of embryonic expression, before it will be
possible to suggest a potential function for these molecules during early blood
vessel development.
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1.3.9.  Transcription factors
Surprisingly little is known about the transcription factors involved in
regulation of early blood vessel development.  Indeed, even those transcription
factors that are known to be expressed in vascular endothelial cells usually show
expression in additional embryonic tissues.  A rather typical example is the
homeodomain transcription factor hex.  Hex is expressed in the embryonic
endoderm, the developing liver and also in endothelial precursor cells (Newman
et al., 1997; Thomas et al., 1998; Yatskievych et al., 1999).  In the Xenopus
embryo, overexpression of hex causes an increase in the number of endothelial
cells (Newman et al., 1997) suggesting a role in differentiation or proliferation.
Ablation of hex function in mouse, produces liver and anterior patterning defects,
consistent with its known embryonic expression domains, but no discernible
vascular phenotype, possibly because other factors compensate for its absence in
endothelial cells (Barbera et al., 2000).
Another transcription factor implicated in vascular development is
gridlock.  The gridlock (gr1), mutation in zebrafish was originally recognized
because it causes a blockage in circulation to the posterior trunk and tail due to an
obstruction in the aorta (Weinstein et al., 1995).  The gr1  gene has been
positionally cloned and encodes a novel transcription factor of the bHLH family
that is expressed in the heart region and dorsal aorta (Zhong et al., 2000). Related
gene members of this family acts as transcriptional repressors downstream of
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Notch signaling in mice (Nakagawa et al., 2000).  A recent study reports that gr1
is essential for arterial specification in zebrafish, acting as a downstream effector
of Notch signaling (Zhong et al., 2001).  However, this data conflicts with another
study that found that blocking Notch signaling in an identical fashion did not
cause a change in grl expression, although the expression of the arterial marker
ephrinB2 was diminished (Lawson et al., 2001). This suggests that grl may not be
as important for arterial specification as originally claimed.
Members of the Ets family of transcription factors are widely expressed in
vascular endothelial cells and have been implicated in the regulation of vascular
genes.  In particular, specific Ets binding sites have been identified in the
promoter regions of  many endothelial genes, including VEGFR1 (Wakiya et al.,
1996) and also members of the matrix metalloproteinase family, which are
involved in vascular remodeling (Yamamoto et al., 1998;  Hiraoka et al., 1998).
However, the high redundancy within the family makes assessment of the role of
specific Ets family proteins difficult.  For example, genetic ablation of Ets-1 itself
produces viable offspring with no vascular defects, presumably due to the
rescuing function of other Ets family genes (Barton et al., 1998).  Some members
of the Ets family are more clearly involved in endothelial cell gene regulation.  In
the case of fli1, which shows high levels of expression in embryonic angioblasts
(Brown et al., 2000), genetic ablation leads to impaired hematopoiesis and also
widespread hemorrhaging, including leakage from the dorsal aorta (Spyropoulos
et al., 2000).  The Ets transcription factor TEL, is expressed in a range of different
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embryonic tissues and mouse embryos lacking TEL function display defects in
yolk sac angiogenesis (Wang et al., 1997).  The Ets family sequence erg is also
expressed at high levels in the embryonic vasculature but a specific function
remains to be determined (Baltzinger et al., 1999).
The transcription factor SCL/Tal is expressed in both endothelial and
hematopoietic progenitor cells (Kallianpur et al., 1994; Drake et al., 1997; Gering
et al., 1998; Drake and Fleming, 2000).  The primary role of SCL seems to be in
specifying blood development since targeted disruption of the gene results in
embryos that lack blood but still contain endothelial tubes (Shivdasani et al.,
1995).  However, conditional SCL mutants, in which blood formation has been
rescued, die from defects in remodeling of yolk sac blood vessels (Visvader et al.,
1998), clearly indicating a role for SCL in embryonic vascular development.
1.4.  CONCLUSION
In 1922, the pioneering embryologist Florence Sabin remarked on the
origins of blood vessels that "We know just how blood-vessels begin" (Sabin,
1922).  As it turned out, her brilliant insights into vascular development
represented only the beginnings of the journey towards understanding fomation of
the vascular system.  Over the last decade in particular, there has been an
explosion in our knowledge of the cellular and molecular mechanisms underlying
all facets of vascular development.  Perhaps the most obvious conclusion from
these recent studies is that the process of vascular development is inherently
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complex.  While a significant amount is known about some of the signaling
pathways, structural proteins and transcription factors involved in blood vessel
formation, other important molecules remain essentially uncharacterized.  Now
that complete genome sequences are becoming available and high throughput
analysis of gene expression patterns is routine, identification of yet more
molecules involved in vascular development can be expected to proceed at an
unprecedented rate.  The placement of these new molecules within genetic
hierarchies and signaling pathways and their integration into existing regulatory
networks will represent the next great challenge on the road leading towards the
understanding of vascular development.
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Chapter 2: Endoderm is Required for Vascular Endothelial Tube
Formation, but not for Angioblast Specification2
2.1. INTRODUCTION
The primary network of blood vessels in the embryo is formed by the
process of vasculogenesis, which is defined as the de novo formation of blood
vessels by the aggregation of individual angioblasts.  At a fundamental level, the
first step in vasculogenesis involves the specification of endothelial cell
precursors (angioblasts) from mesoderm.  Subsequently, the angioblasts
proliferate and coalesce into cords that then form continuous strands of
endothelial cells.  These cells then form tubular vascular structures.  The process
of tube formation is initiated when a ‘slit-like’ space opens up between two
angioblasts.  These spaces enlarge, combining with other such spaces to form a
hollow endothelial tube (Houser et al., 1961).  At least in some cases, lumen
formation precedes the formation of a continuous endothelial network (Hirakow
and Hiruma, 1983; Drake and Jacobson, 1988; reviewed in Risau and Flamme,
1995; Wilting and Christ, 1996; Roman and Weinstein, 2000; Vokes and Krieg,
2001). Subsequent elaboration of the vascular network occurs via angiogenesis,
                                                 
2 This chapter has been previously published under the title “Endoderm is required for vascular
endothelial tube formation, but not for angioblast specification” in the journal Development 129:
775-785 (2002).  Reproduced with permission by the Company of Biologists Ltd.  Plastic sections
and electron microscopy were performed by Peggy McCuskey and Gina Zhang.  Janet Heasman
and Matt Kofron provided VegT cDNA samples, Xenopus bFGF was provided by David
Kimelman.  Tatiana Yatskievych assisted with the quail experiments.
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which is the growth and extension of vessels from the pre-existing vascular
network (for a recent review, see Carmeliet, 2000).
A number of signaling pathways are known to play regulatory roles during
embryonic vasculogenesis.  At the earliest stages of vascular development, the
VEGF signaling pathway is essential for blood vessel formation (Shalaby et al.,
1995; Carmeliet et al., 1996; Ferrara et al., 1996).  The VEGF ligand is bound by
two high affinity receptors, VEGFR2 (Flk-1/KDR) and VEGFR1 (Flt-1), both of
which belong to the tyrosine kinase receptor family. Flk-1 is expressed
exclusively in vascular endothelial cells, and represents the earliest known
specific marker of endothelial cells.  In addition to its role as a mitogen, VEGF
also acts as a chemoattractant for endothelial cells (Waltenberger et al., 1994;
Cleaver and Krieg, 1998; Ash and Overbeek, 2000), and is also involved in the
correct assembly of endothelial cells into lumenated vessels (Drake et al., 2000).
Ablation of VEGF expression results in an almost complete block to vascular
development (Carmeliet et al., 1996, Ferrara et al., 1996).  On the other hand,
expression of excess VEGF ligand in the embryo results in both
hypervascularization and also formation of abnormally large vascular lumens
(Drake and Little, 1995; Flamme et al., 1995b; Cleaver et al., 1997).  Following
the formation of the original vascular network, numerous other growth factor
signaling pathways are involved in the subsequent remodeling and maturation of
the vascular system (reviewed in Yancopoulos et al., 2000).
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In amniotes, the formation of primary vascular networks occurs in two
distinct regions.  Extraembryonic vasculogenesis is observed in the yolk sac blood
islands, while intraembryonic vasculogenesis occurs within the developing
embryo itself. Classical embryological experiments have demonstrated that
formation of the two vascular systems is not developmentally linked since
assembly of the intraembryonic vascular network is completely independent of
extraembryonic vasculogenesis (Hahn, 1909; Miller and McWhorter; 1914;
Reagan, 1915).  On the other hand, in organisms such as teleosts (bony fishes)
and amphibians, all vasculogenesis occurs intraembryonically (Stockard, 1915b).
A major difference between extraembryonic angioblasts and intraembryonic
angioblasts lies in their organization.  Extraembryonic angioblasts originate in
blood islands, containing an outer layer of endothelial cells and an inner layer of
red blood cells.  In contrast, intraembryonic endothelial precursors are almost
always first observed as solitary angioblasts (Risau, 1995) and these can arise in
any mesodermal tissue in the embryo with the exception of the prechordal
mesoderm (Noden, 1989; Wilms et al., 1991; Wilting et al., 1995).  Only in
certain specific, rare, instances are these intraembryonic angioblasts closely
associated with blood cells (Cormier and Dieterlen-Lièvre, 1988, Olah, et al.,
1988; Jaffredo et al., 1998; Ciau-Uitz et al., 2000).  Based on the remarkable
ability of diverse mesodermal tissues to form angioblasts, it appears that the tissue
environment in and around a specific region of mesoderm is responsible for
regulating vascular endothelial cell specification and commitment (Noden, 1989;
Pardanaud et al., 1989; Pardanaud and Dieterlen-Lièvre, 1999; Cox and Poole,
 57
2000).  Although both intraembryonic and extraembryonic angioblasts are of
mesodermal origin, the different environments in which they arise and the
differences in the fate of associated cells raises the possibility that the two
populations may be specified by different mechanisms.
At present, the precise origin of the embryonic angioblast lineage is
uncertain.  Numerous anatomical studies have shown that angioblasts in the
extraembryonic blood islands, and also in the earliest intraembryonic blood
vessels, arise in close proximity to endoderm (Mato et al., 1964; Gonzalez-Crussi,
1971; Mobbs and McMillan, 1979; Meier, 1980; Kessel and Fabian, 1985;
Pardanaud et al., 1989).  Based on these observations, Wilt (1965) proposed that
direct interactions between the endoderm and mesoderm might be required for
angioblast induction, and this possibility has been investigated in a number of
different studies carried out using the avian embryo (Wilt, 1965; Miura and Wilt,
1969; Pardanaud et al., 1989; Pardanaud and Dieterlen-Lièvre, 1993).  In chick
tissue culture experiments, when specific portions of the area vasculosa that form
the extraembryonic blood islands were separated into the mesectodermal and
endodermal components, the mesectodermal component failed to generate
detectable endothelial cell enclosed blood islands (Wilt, 1965).  Endothelial cell
differentiation could be restored if the mesectoderm was recombined with
endoderm.  This suggests that an endodermally derived inductive signal is
necessary for extraembryonic endothelial cell formation, at least in the context of
blood island formation.  This result was corroborated in a subsequent study
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(Miura and Wilt, 1969).  While these studies implied that endoderm is required
for blood island formation, in the absence of molecular markers it was not
possible to identify individual angioblasts prior to blood vessel formation, and so
the results are not necessarily conclusive.
In studies of intraembryonic vasculogenesis, Pardanaud et al (1989) also
proposed that interactions between mesodermal and endodermal tissues are
necessary for vasculogenesis.  Once again, this proposal was based on the fact
that vasculogenic mesoderm is always observed in the immediate vicinity of
endoderm.  This hypothesis was extended in a subsequent study showing that,
when grafted onto chick limb buds, quail splanchnopleuric mesoderm (which is in
contact with endoderm) generated greatly more endothelial cells than
somatopleuric mesoderm (not in contact with endoderm).  On the basis of this
result, it was concluded that an endodermal factor is necessary to promote the
emergence of endothelial cells (Pardanaud and Dieterlen-Lièvre, 1993). More
recently, it has been argued that an indian hedgehog signal from the visceral
endoderm is necessary for specifying endothelial cell fate in mouse embryos
(Belaoussoff et al., 1998; Dyer et al., 2001).  Overall these studies imply that
interactions between endoderm and mesoderm are required for vascular
endothelial cell specification.  Notwithstanding a large number of assumptions
and a relative paucity of experimental support, this relationship is routinely stated
in the literature and has largely assumed the status of dogma (Wilt, 1965; Miura
and Wilt, 1969; Gonzalez-Crussi, 1971; Augustine, 1981; Kessel and Fabian,
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1985; Pardanaud et al., 1989; Pardanaud and Dieterlen-Lièvre, 1993; Risau and
Flamme, 1995; Sugi and Markwald, 1996; Belaoussoff et al., 1998; Waldo and
Kirby, 1998; Cleaver and Krieg, 1999; Roman and Weinstein, 2000; Dyer et al.,
2001; Poole et al., 2001).
Despite the widespread acceptance of a role for endoderm in angioblast
specification, a number of experiment results using several different organisms
have called this conclusion into question (see Discussion).  It is important to
acknowledge however, that none of these studies had been designed to
specifically address the requirement of endoderm for angioblast formation and so
none of the studies were fully controlled.  To formally address this question, we
have used a combination of molecular and classical embryology techniques to
examine the role of endodermal tissues during vasculogenesis.  We find that large
numbers of angioblasts are formed in frog embryos that contain no detectable
endoderm.  However, angioblasts in these endoderm depleted embryos fail to
assemble into endothelial tubes.  This observation was confirmed in
complementary experiments using avian embryos.  In summary, our studies
indicate that endoderm is indeed important for vascular development, not for
angioblast specification, but for the formation of tubular blood vessels.
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2.2. THE ROLE OF ENDODERM IN VASCULAR SPECIFICATION
2.2.1.  Angioblast formation after manual removal of endoderm
Using the frog embryo, we have carried out a series of experiments to test
whether interactions between endodermal and mesodermal tissues are required for
the formation of angioblasts.  Our initial experiments used standard
embryological techniques to physically remove the vast majority of endoderm
from the gastrula stage Xenopus embryo.  This dissection is closely modeled on
methods previously described by Cooke (1989) and Nascone and Mercola (1995).
Both of these studies showed that endoderm acts as a permissive signal that is
essential for cardiac development.  We used tungsten needles and hair loops to
carefully remove all detectable endoderm from stage 10 embryos (Fig. 5A) and
then allowed the manipulated embryos to develop until control embryos showed
the presence of a beating heart (about stage 34).  As expected, none of the
endoderm-depleted embryos (0/24) showed the presence of beating cardiac tissue
(data not shown) thereby indicating successful removal of endoderm (Cooke,
1989; Nascone and Mercola, 1995).  Apart from a loss of a large proportion of the
total tissue mass, endodermless embryos exhibited a generally normal overall
body pattern, including segmented somites and morphologically intact notochords
and neural tubes.  As described by Cooke (1989), the ventral region of the
embryos consisted primarily of “lateroventral mesoderm,” although the precise
nature of this tissue is uncertain.  Endoderm depleted embryos, at the equivalent
of stage 34, were assayed for the presence of angioblast cells by in situ
hybridization using several distinct angioblast marker probes, including X-msr,
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Figure 5. Endoderm is not necessary for in vivo angioblast specification.
(A) Schematic of the dissection used to remove endoderm.  The vegetal core (red),
comprising future endoderm, was removed from embryos at the onset of gastrulation, and
the resulting endoderm depleted embryos were incubated until stage 34.  (B, D, F)
Control embryos assayed with X-msr, erg and flk-1 probes respectively.  These show
elaborate vascularization, including posterior cardinal veins (pcv; closed arrowhead),
intersomitic vessels (is; open arrowhead), and a ventrolateral vascular plexus.  (C, E, G)
Endoderm depleted embryos, assayed with X-msr, erg and flk-1 probes respectively,
contain angioblasts (white open arrowheads), but these are not organized into patent
blood vessels.
 62
flk-1 and erg.  Using the in situ method, expression of these markers is first
detected in developing vascular tissues at the late neurula stage (approx. stage 18)
(Cleaver et al., 1997; Baltzinger et al., 1999).  Surprisingly, all endoderm
depleted embryos examined showed the presence of significant numbers of
angioblasts.  This was particularly evident in lateral regions of the embryos which
showed strong expression of X-msr (14/14 embryos; Fig. 5C), erg (5/5 embryos;
Fig. 5E) and flk-1 (5/5 embryos; Fig. 5G).  In order to confirm, and control, these
in situ hybridization observations, endodermless embryos were assayed for
vascular markers and a number of endodermal markers by RT-PCR analysis (Fig.
6).  In this analysis, thepresence of angioblasts was assessed using erg and flk-1.
We did not use X-msr in the RT-PCR assays because this gene is expressed in an
additional, apparently non-endothelial, domain at the tip of the tail (Fig. 5B, C)
that might confuse interpretation of the results.  As shown in Fig. 6, RT-PCR
analysis indicates that angioblast markers f lk-1 and e r g, and the
angioblast/hematopoietic cell marker, SCL/tal-1 (Mead et al., 1998) are expressed
at significant levels in endoderm depleted embryos.  To determine the efficiency
with which endodermal cells were eliminated by physical dissection, RT-PCR
analysis was carried out on RNA samples from the same manipulated embryos,
using a number of different markers of endodermal tissue.  This assay reveals that
expression of the definitive endodermal markers insulin, IFABP and xlhbox8, is
almost completely eliminated in manipulated embryos, indicating that removal of
endoderm, although not complete, has been very effective.  Another commonly
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Figure 6.  Endodermless embryos show a marked reduction in expression of endodermal
markers but still express endothelial markers.
RT-PCR was performed on total RNA from a stage 34 endodermless embryo.
Expression levels of the endodermal markers insulin, IFABP and xlhbox8 are either
severely reduced or eliminated relative to unmanipulated controls, while the vascular
markers flk-1 and erg and the angioblast/hematopoietic cell marker SCL/tal-1, are still
present.
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used endodermal marker, endodermin, is detected at quite high levels in
endoderm-depleted embryos, but this is presumably because of its additional
expression domain in the paraxial mesoderm, especially the notochord (Sasai et
al., 1996 and data not shown).  Note also that the general muscle marker, cardiac
α-actin is expressed at normal levels in the manipulated embryos while, as
expected, expression of the heart specific marker cardiac troponin I is
undetectable (Fig. 6).  We believe that the slightly reduced levels of angioblast
markers in endoderm-depleted embryos may be due to reduced angioblast
proliferation, because in normal embryos the endoderm expresses substantial
amounts of VEGF (Cleaver et al., 1997), which is a potent mitogen for
angioblasts (Keyt et al., 1996).  Overall, these dissection experiments indicate that
angioblasts are specified at significant levels in embryos from which endoderm
has been greatly depleted or eliminated
2.2.2. Angioblast formation in embryos with reduced-VegT function.
VegT function is essential for endoderm formation in the frog embryo and
has recently been shown to be the crucial initiating molecule underlying all
endoderm specification (Xanthos, et al., 2001).  Treatment of embryos with VegT
antisense oligonucleotides results in abolition of all detectable endodermal tissue
(Zhang et al., 1998) and, at higher doses can cause elimination of as much as 90%
of mesodermal tissue (Kofron et al., 1999).  To complement our studies in which
endoderm was physically removed, we have assayed for angioblast formation in
embryos treated with VegT antisense phosphorothioate oligonucleotides at levels
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sufficient to eliminate endodermal tissue (5-8 ng per embryo).  Since the antisense
oligonucleotide acts prior to fertilization, optimally treated embryos should not
contain endoderm at any stage of development.  Analysis of treated embryos by
RT-PCR shows severe reduction or elimination of expression of all endodermal
markers tested, including endodermin, IFABP, Xlhbox8 and insulin (Fig. 7).  In
this experiment, we believe that endodermin expression is completely absent
because VegT depletion also results in down regulation of many mesodermal
genes (Kofron et al., 1999).  Importantly however, the experimental embryos
continue to show expression of the vascular-specific markers flk-1 and erg, and
the angioblast/hematopoietic cell marker SCL/tal-1, although at somewhat
reduced levels compared to wild type embryos.  Complete rescue of embryos, by
injection of VegT mRNA, restores flk and erg expression to normal levels.  When
antisense VegT-treated embryos are partially rescued by microinjection with
eFGF mRNA, which restores ventrolateral mesodermal levels to wild-type while
specifically excluding endoderm (Kofron et al., 1999), expression of the vascular
markers flk-1 and erg is restored to wild type levels (Fig. 7).  No expression of
endodermal markers is detected in the eFGF-rescued embryos.  Taken together,
these experiments using VegT-depleted embryos strongly imply that formation of
embryonic angioblasts is not dependent on the presence of endodermal tissue.
2.2.3.  Angioblasts form in FGF-treated animal caps that contain no
endoderm
The experiments described in the preceding sections do not formally
preclude the possibility that very small amounts of endoderm are sufficient for the
induction of angioblasts or, in the case of the embryonic dissection experiments,
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Figure 7.  Embryos depleted of endoderm by treatment with VegT antisense
oligonucleotides continue to express vascular markers.
RT-PCR analysis of RNA from stage 34 embryos shows a lack of endodermal markers in
VegT treated embryos (labeled VegT-), while vascular markers are still present.  Rescue
by co-injection of VegT mRNA (labeled Rescue) restores both endodermal and
mesodermal markers to control levels, whereas partial rescue with eFGF (labeled VegT-
eFGF) restores mesodermal marker expression but has no effect on endodermal markers
(Kofron et al., 1999).
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that a transient interaction of mesoderm and endoderm prior to stage 10.5, is
adequate to specify the lineage.  To address these two possibilities, we have
employed animal cap techniques to generate mesodermal tissue that has never
come into contact with endoderm.  Specifically, we treated animal caps with basic
fibroblast growth factor (bFGF) under conditions that generate mesoderm
completely free of endoderm (see materials and methods; Cornell et al., 1995;
Gamer and Wright, 1995).  At the equivalent of stage 30, the caps were assayed
using RT-PCR for expression of a range of endothelial, mesodermal and
endodermal tissue markers.  Stage 30 was chosen because all endothelial markers
are expressed at significant levels in wild type embryos at this time.  As shown in
Fig. 8A animal caps treated with 100ng/ml of bFGF express the endothelial
markers flk-1 and erg, and the angioblast/hematopoietic cell marker SCL/tal-1, as
well as the general mesodermal marker cardiac α-actin. There is however, no
detectable expression of the endodermal markers endodermin, Xsox17-α, insulin,
IFABP and xlhbox8.  While endodermin is detected in manually dissected
endodermless embryos, probably due to its expression in paraxial mesoderm, it is
not present in bFGF induced animal caps (Sasai et al., 1996).  This is most likely
because bFGF does not induce the expression of genes representing more dorsal
mesodermal tissues such as notochord (Green et al., 1990).  We also note that the
early endodermal marker mixer is not present in stage 30 control embryos in
agreement with its published expression pattern (Henry and Melton, 1998).  To
ensure that endodermal tissue was not transiently present soon after bFGF
treatment, animal caps were also assayed for marker expression at the late
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Figure 8. Animal caps treated with bFGF form mesoderm containing endothelial markers
in the absence of detectable endoderm.
(A) Animal caps were incubated in bFGF and cultured until the appropriate stage (either
12.5 or 30).  Caps were then assayed for early or late markers of endoderm and for
endothelial markers using RT-PCR.  While the animal caps show expression of both
endothelial and mesodermal markers, there is no detectable expression of endodermal
markers at either stage.  Note that significant expression of endothelial markers is not
expected in the stage 12.5 samples.  (B) Stage 30 animal caps treated with bFGF express
the vascular marker X-msr in discrete patches when assayed by in situ hybridization.
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gastrula stage (Stage 12.5).  Whereas treated caps express Xbra, indicating the
presence of early mesodermal tissue, they do not express the early endodermal
markers endodermin, Xsox17-α and mixer.  The vascular markers flk-1 and erg are
also absent at this stage, in agreement with their known embryonic expression
profiles (Cleaver et al., 1997; Baltzinger et al., 1999).  In order to determine the
distribution of endothelial cells in FGF treated caps, we examined the stage 30
animal caps for the presence of vascular markers by in situ hybridization.  As
shown in Fig. 8B, the vascular marker X-msr reveals the presence of individual
angioblasts in treated caps, but not in untreated control caps.
2.3.  ENDODERM IS REQUIRED FOR ENDOTHELIAL TUBULE ASSEMBLY
We have carried out three independent sets of experiments, physical
dissection, VegT ablation and induction of mesoderm in animal caps, all of which
suggest that angioblast specification is independent of interactions with
endoderm.  Does this imply that endoderm plays no role at all in the development
of the embryonic vascular system?  In fact, results presented below strongly
support a role for endoderm during assembly of angioblasts into patent vascular
tubes.
As described in the preceding section, embryos from which endoderm had
been physically dissected at stage 10.5 showed the presence of an abundance of
aggregated cords of angioblasts during later development (stage 34) (Figs. 5C, 1E
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and 1G).  In no case however, did we observe angioblasts assembling into the
patent blood vessels visible in the control embryos.  In order to ensure that this
was not merely the consequence of a developmentally delayed phenotype,
endoderm-depleted embryos were incubated until stage 37.  At this stage, all
embryos contained dark eye pigment and melanocytes, clear indications that they
had developed past the stage when blood vessel tube formation would normally
occur (about stage 34; Cleaver et al., 1997).  When these endoderm-depleted
embryos were assayed by in situ hybridization for the vascular marker X-msr,
angioblasts, but no endothelial tubes, were visible in wholemount embryos (Figs.
9B and 9C).  In sectioned embryos, thick assemblages of angioblasts were visible
in lateral regions of the embryo (Fig. 9F).  However, despite the presence of large
numbers of angioblasts, none of the endoderm-depleted embryos (0/21) contained
any detectable vascular tubes.  On the other hand, patent vessels were readily
visible in all control embryos (15/15 examined; Fig. 9E).
To ensure that the absence of tube formation by angioblasts in endoderm
depleted embryos was indeed due to the absence of endoderm rather than a
dissection artifact, we carried out a rescue experiment.  In this experiment, stage
10 embryos from which endoderm had been removed were implanted with a small
amount of vegetal core tissue from a sibling embryo.  We estimate that
approximately 20% of the normal amount of endodermal tissue was restored to
the embryo.  In all cases (11/11), the rescued embryos exhibited much improved
overall morphology and also a substantial degree of vascular assembly and tube
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Figure 9.  Endoderm is required for endothelial tube formation.
(A) Wild-type stage 37 embryo showing posterior cardinal vein (closed arrowhead),
intersomitic vessels (open arrowhead) and a prominent vascular plexus. (B, C) Stage 37
embryos deprived of endoderm at stage 10 contain thick assemblages of angioblasts
(closed arrowheads), but do not contain endothelial tubes.  (D) Stage 37 embryo deprived
of endoderm at stage 10 and rescued by the addition of a vegetal plug of endoderm from
a sibling embryo.  Note the presence of posterior cardinal veins (closed arrowhead) and
intersomitic vessels (open arrowhead).  (E) Cross-section through a wild-type stage 37
embryo showing posterior cardinal vein (closed arrowhead) and dorsal aorta (open
arrowhead).  (F) Cross-section through a stage 37 endodermless embryo showing
presence of angioblasts (closed arrowhead) but no assembly into endothelial tubes.  All
embryos were assayed by in situ hybridization with the vascular marker X-msr.
Abbreviations: e, endoderm; n, notochord; nt, neural tube.
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formation.  Phenotypes ranged from formation of a vascular plexus, generally
restricted to the ventral region of the embryo, up to an almost complete vascular
network that contained paired posterior cardinal veins and intersomitic vessels
(Fig. 9D).  The presence of patent blood vessel morphology was examined more
closely in serial, plastic, semi-thin sections from additional endoderm depleted
and rescued embryos.  These embryos were not assayed by in situ hybridization
because we find that the in situ procedure makes the embryos brittle and
compromises histological quality, especially for delicate structures like blood
vessels.  In this experiment, only 2/11 endoderm depleted embryos showed any
discernible endothelial tubes in any section along the length of the embryo (Fig.
10B) for a total of 55 sections examined.  In contrast, 6/8 rescued embryos
showed the clear presence of vascular tubes (Fig. 10C).  These results are
statistically significant (P < 0.05).  Representative transverse sections through
posterior cardinal veins from wild type and rescued embryos were also examined
by electron microscopy (Fig. 10D and 10E respectively).   Based on examination
of numerous sections, endothelial tube structures in the rescued embryos were
morphologically indistinguishable from those in wild-type embryos.
The original experiments of Wilt and Miura suggesting a role for
endoderm in angioblast specification were carried out using avian embryos (Wilt,
1965; Miura and Wilt, 1969).  These experiments clearly indicated an absence of
endothelium enclosed blood islands in endoderm depleted embryos but, without
the aid of molecular markers, it was not possible to determine whether angioblasts
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Figure 10.  Embryos without endoderm lack patent blood vessels.
(A-C) 1µm plastic sections stained with toluidene blue.  (A) Cross-section through a
wild-type stage 37 embryo showing endothelial tubes, including a posterior cardinal vein
(closed arrowhead) and dorsal aorta (open arrowhead).  (B) Endothelial tubes are not
present in stage 37 endodermless embryo but are present in stage 37 embryos that have
been rescued by the addition of endoderm (C).  (D, E) Transmission electron microscopy
showing transverse sections through the posterior cardinal veins of a wild-type embryo
(D) and an endodermless embryo rescued by the addition of endoderm from a sibling
donor embryo (E).  Arrows indicate the characteristic thin-walled endothelial cell
morphology in each section.  Scale bar equals 1 µm.  Black dots in sections are lipid
droplets generated during histological preparation.  Abbreviations: e, endoderm; n,
notochord; nt, neural tube.
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were indeed present.  To address this question, we have examined vascular
development in endoderm depleted quail embryos using the angioblast marker,
QH1 (Pardanaud et al., 1987).  For these experiments, both intra- and
extraembryonic endoderm was removed from the left side of stage 5 embryos,
with the unmanipulated right side serving as an internal control.   Embryos were
cultured for approximately 12 hours until they had approximately 6 somites (stage
9-).  We assayed embryos at this stage, rather than later in development, to ensure
that the vasculature was formed exclusively by vasculogenic mechanisms.  Using
the quail endothelial cell-specific antibody QH1, 8/8 embryos examined contained
no discernible endothelial tubes on the side lacking endoderm, although all
embryos had robust vascular development on the control side (Fig. 11A and 11B).
This result is statistically significant (P< 0.01).  Despite the absence of blood
vessels, all embryos showed the presence of abundant QH1 positive cells on the
endodermless side, indicating that angioblasts were still specified in the absence
of endoderm.  Basically these experiments in the quail embryo support the
original observations of Wilt (1965) that endoderm is required for formation of
organized endothelial structures.  The underlying reason however, is not the
absence of angioblasts, but the failure of these cells to assemble into patent blood
vessels.
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Figure 11.  Removal of endoderm in quail embryos does not prevent
angioblast formation.
(A).  Ventral view of quail embryo showing approximate region from which
endoderm was removed.  (B, C) Ventral images of fluorescent staining of the
endothelial cell marker, QH1 at approximately the four and six-somite stages
respectively.  The endoderm depleted side is on the right.  Note the presence of
endothelial cells within the manipulated region, but the absence of vascular
assembly.  The approximate midline of the embryo is indicated by the dashed
line.  Scale bar equals 10 µm.
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2.4.  DISCUSSION
2.4.1.  Angioblast specification does not require endoderm
Based on three distinct experimental approaches in two different model
systems, our results indicate that embryonic specification of angioblasts is
independent of the presence of endoderm.  Using the Xenopus embryo, consistent
results are obtained when endoderm is removed by embryonic dissection, when
endoderm is ablated using antisense VegT oligonucleotides and when
mesodermal tissue is induced in animal caps in the complete absence of detectable
endoderm.  In the avian embryo, angioblasts still form when endoderm is
physically removed.  Overall, these results directly challenge the broadly cited
proposition that interactions between mesoderm and endoderm are necessary to
specify endothelial cells (Wilt, 1965; Miura and Wilt, 1969; Gonzalez-Crussi,
1971; Kessel and Fabian, 1985; Pardanaud et al., 1989; Pardanaud and Dieterlen-
Lièvre, 1993; Sugi and Markwald, 1996, Belaoussoff et al., 1998; Dyer et al.,
2001, and stated in numerous reviews including Augustine, 1981; Risau and
Flamme, 1995; Cleaver and Krieg, 1999; Roman and Weinstein, 2000; Poole et
al., 2001).
Although this study is amongst the first to use molecular markers to
directly address the role of endoderm in angioblast specification, it is important to
acknowledge that a number of previous studies, using different experimental
systems, have hinted that endodermal-mesodermal interactions are not essential
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for the formation of angioblasts.  For example, it has been shown that mouse
embryoid bodies lacking activity of the transcription factor GATA-4, fail to form
extraembryonic endoderm.  In the absence of endoderm, these embryoid bodies
are unable to form endothelial cell enclosed blood islands.  This observation is in
apparent agreement with the endoderm induction model.  However, use of
specific markers indicated that vascular endothelial cells were still present in
these embryoid body cultures (Bielinska et al., 1996).  Similar results were
obtained embryologically by Palis et al (1995), who showed that murine yolk sac
explants that contained extraembryonic mesoderm, but were separated from
endoderm, still developed endothelial cells, but lacked organized blood vessels.
In this experiment however, dissections were performed at E7.5.  Since
extraembryonic angioblasts are initially detected at E6.5 (Drake and Fleming,
2000), it is possible that angioblasts had already been specified prior to the
separation of mesoderm from endoderm.
Further evidence that angioblasts form in the absence of endoderm is
provided by a series of experiments using quail-chick heterochronic chimeras.  In
these experiments, quail blastoderm treated with cytochalasin B to block
gastrulation was grafted to host limb buds.  The presence of endothelial cells was
then assessed using the antibody QH-1.  Because limb buds do not contain
endoderm, the presence of quail endothelial cells in these chimeras implied that
the endodermal germ layer is not necessary for vascular cell specification (Christ
et al., 1991; von Kirschhofer et al., 1994; Wilting and Christ, 1996).  However,
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interpretation of the limb bud experiments in the context of endothelial cell
specification is difficult since they utilized an older, already specified population
of mesoderm that contains a complex and specific set of growth factors involved
in limb bud patterning.
Studies of zebrafish mutants that are deficient in endoderm formation also
support our suggestion that endoderm is not necessary for vascular specification.
For example, one-eyed pinhead (oep) mutants lack almost all endoderm (Schier et
al., 1997) but still contain abundant angioblasts (Brown et al., 2000).  In these
mutants however, at least some endodermal tissue is still present and so the
absolute requirement for endoderm in angioblast formation is difficult to
ascertain.
Some recent molecular studies using mouse tissues would appear to
directly contradict our conclusions.  In particular, Belaoussof et al (1998) have
suggested that an early signal from the visceral endoderm can respecify
neurectoderm to a posterior mesodermal cell fate containing both endothelial and
blood markers.  It was concluded that a secreted signal from the visceral
endoderm is needed to induce endothelial cell fate.  Subsequent work has
suggested that indian hedgehog (Ihh) is the secreted signaling factor (Dyer et al.,
2001).  This result is challenged by gene ablation studies in mice which show that
embryos lacking function of either Ihh or Smoothened (the receptor for all
hedgehog proteins) still contain at least rudimentary endothelial tubes in the yolk
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sac (Byrd et al., in press).  This result conclusively demonstrates that hedgehog
signaling is not necessary for angioblast specification, at least in an in vivo
context.  The tissue recombination work (Belaoussof et al., 1998) implying that
visceral endoderm is required to induce endothelial cells, is a more complicated
issue.  However, we propose that the function of visceral endoderm in these
experiments is in fact the induction of mesodermal tissue, since this is not present
in the original explants.  Once mesoderm is present, it is then capable of forming
angioblasts, precisely as observed in our experiments.  Alternatively, it is possible
that the mechanism leading to specification of angioblasts in frog and avian
embryos differs from that operating in the mammalian embryo.
2.4.2.  Endoderm is required for endothelial tube formation
Our experiments show that angioblasts are indeed present in embryos
containing no endoderm.  However, these angioblasts fail to assemble into patent
vascular tubes.  Serial sectioning through endoderm depleted embryos shows that
formation of tubular blood vessels is absent or severely reduced (Fig. 10B),
although in situ hybridization indicates that angioblasts have assembled into
dense, cord-like aggregations throughout the trunk of the embryo (Fig. 9B and
9C).  These observations suggest that vasculogenesis in endoderm depleted
embryos is interrupted at a step prior to tube formation.  This view is supported by
the rescue experiments in which endoderm from a donor embryo is implanted into
the endoderm-depleted embryo.  Despite the trauma caused by this rather crude
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manipulation, the majority of rescued embryos show vascular tube formation.  In
the most effective cases, the rescued embryos showed clear organization of the
posterior cardinal veins and intersomitic vessels.  Variation in the amount of
vascular structure observed in different rescued embryos is presumably due to
differential healing, but we cannot exclude the possibility that pre-patterning of
the endoderm has already occurred and therefore the degree of vascular rescue
may be related to the orientation of the implanted endodermal tissue.  In
agreement with our results using Xenopus, we note that zebrafish oep mutants,
which lack most endoderm, contain angioblasts but exhibit dramatic defects in
axial vascular formation, and lack a functional circulatory system (Brown et al.,
2000), suggesting that endoderm is indeed required for vascular assembly.
Likewise, murine extraembryonic mesoderm, when isolated from endoderm,
forms endothelial cells that fail to assemble into vascular tubes (Palis et al., 1995;
Bielinska et al., 1996).
The results of these experiments raise two fundamental questions relating
to the mechanisms underlying vascular development.  First, what is the molecular
nature of the endodermal signal necessary for vascular tubulogenesis?  This
question will be examined extensively in the following chapter.  The second
question is related to the observation that endoderm is not involved in angioblast
specification.  This implies that any signal for angioblast specification arises
within the mesoderm itself.  The ectodermal germ layer, the only other
theoretically possible source of inductive signals, is not likely to contribute to
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vasculogenesis because it has been shown to profoundly inhibit vasculogenesis
(Feinberg et al., 1983; Wilson et al., 1989; Pardanaud and Dieterlen-Lièvre, 1993;
1999).  While our results suggest that the origin of the angioblast specification
signal is likely to be exclusively mesodermal, the molecular nature of the signal is
completely unknown.  Because almost all mesoderm has the potential to express
angioblasts (Noden, 1989), it is possible that angioblast specification occurs by an
inherent patterning mechanism, perhaps analogous to the Delta/Notch signaling
pathway responsible for neuroblast specification in Drosophila.  Inhibitory signals
from ectodermal tissues may subsequently help to determine the boundaries of the
vasculogenic network.
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Chapter 3: Sonic Hedgehog signaling from the endoderm is
essential for the formation of endothelial tubes during
vasculogenesis3
3.1. INTRODUCTION
Growth factors are known to be essential for proliferation of angioblasts
and for the maturation of early endothelial tubes.  For example, signaling by
vascular endothelial growth factor A (hereafter VEGF) through its receptor
VEGFR-2 (Flk-1/KDR) is essential for the formation of blood vessels, and
embryos lacking either of these molecules have few (or no) angioblasts and die
early in development (Shalaby et al., 1995; Carmeliet et al., 1996; Ferrara et al.,
1996).  Within the embryo, initial formation of endothelial tubes always occurs in
mesoderm that is tightly juxtaposed against endoderm, and signals from the
endoderm are essential for the assembly of angioblasts into a functional vascular
network (Vokes and Krieg, 2002a).  Although the morphogenesis of endothelial
tube formation has been described in some detail, little is known about the
molecules that underlie this process (Houser et al., 1961; Gonzalez-Crussi, 1971;
Hirakow and Hiruma, 1983; Drake et al., 1997).
In this study, we demonstrate the molecular identity of this inductive
signal, showing that endodermally derived Sonic hedgehog is both necessary and
sufficient for vascular tube formation in avian embryos. This demonstrates a
                                                 
3 Tatiana Yatskievych assisted with the embryonic manipulations, and contributed the artwork for
Figures 14A,B.  Parker Antin sectioned Figures 14K,I,and M.
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novel role for hedgehog signaling in vascular development and provides a
molecular model for vascular tube formation.
3.2. HEDGEHOG SIGNALING COMPONENTS ARE EXPRESSED IN THE
ENDODERM AND ADJACENT MESODERM
In order to determine the molecular identity of the endoderm-derived
signal we have used the avian embryo as a model system, first because of the ease
with which the endoderm layer can be removed, and second because an
endothelial cell marker antibody, QH1, is available (Pardanaud et al., 1987).  Our
initial experiments were designed to determine the time at which endoderm
signaling is required for vascular assembly.  Endoderm was removed from
3–somite quail embryos, shortly before the first blood vessels form  (Coffin and
Poole, 1988).  When these embryos were assayed for vascular tube formation at
the 8-somite stage, no vascular tubes were present, although abundant
unassembled angioblasts were present (12/12 embryos; Fig. 12A).  Therefore, we
conclude that the endodermal signal is required immediately prior to, or during,
vascular tube formation.
We next examined the expression of candidate growth factors in both the
mesodermal and endodermal layers of 5-somite chick embryos by RT-PCR.  Of
the growth factors examined, only Sonic hedgehog (Shh) was present in the
endoderm and absent from the mesoderm (Fig. 12B and data not shown).  VEGF
was also detected in the endoderm, but was present in the mesoderm in higher
concentrations, and this mesodermal expression was not disrupted by the removal
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of endoderm (Fig. 12B and data not shown).  Because Shh has not previously
been reported in the endoderm of such early embryos, we examined its pattern of
expression by in situ hybridization.  Shh is initially detected in low levels in the
lateral endoderm of 2 and 3-somite embryos (Fig. 12C).  At 4-somites, this
expression domain expands to include almost all embryonic endoderm, and the
level of staining is greatly intensified, a pattern that persists throughout early
development  (Figs. 12D,E).  Additional in situ assays showed that the hedgehog
signaling components patched 1 (ptc1), patched 2 (ptc2) and smoothened (smo)
are expressed in numerous mesodermal tissues, including angioblasts (Figs. 12F-
J).  This is the first report of expression of hedgehog signaling molecules in the
developing vasculature, although at least one previous study shows their presence
in retinal angiogenesis in adult mice (Pola et al., 2001).
3.3. HEDGEHOG SIGNALING IS NECESSARY FOR VASCULAR ASSEMBLY
To determine whether hedgehog signaling plays a role during embryonic
vasculogenesis, embryos were treated with cyclopamine from the 2-somite stage
until approximately 8-somites, by which time the majority of vessels have formed
a lumen (Hirakow and Hiruma, 1983).  Cyclopamine is a specific inhibitor of
hedgehog biosynthesis, and is equally effective at blocking signaling by all
members of the hedgehog family (Incardona et al., 1998; Taipale et al., 2000).
Analysis of blood vessel formation by QH1 immunofluorescence showed that all
embryos treated with 100µM cyclopamine (13/13) exhibited vascular
abnormalities.  These ranged from the presence of small, interrupted tubes, with a
corresponding increase in unassembled clusters of angioblasts, to instances where
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Figure 12. Expression patterns of hedgehog signaling compnonents.
(A)  Endoderm was removed from one half of 3-somite embryos with the other half
serving as a control.  This results in failure of vascular assembly.  (B) RT-PCR on 5-
somite chick  showing presence of Shh in the endoderm and absence in non-axial
mesoderm.  VEGF is present in both the mesoderm and endoderm. Shh  in situ
hybridizations on (C) 2-somite chick embryos showing low levels of endodermal
expression and (D) 8-somite chick embryos showing greatly increased staining. (E,)
Transverse section showing through 8-somite chick embryo showing shh expression in
the endoderm. (F,G) In situ hybridization on a 6-somite quail embryo with ptc1(bright
field) and QH-1 (fluorescence) showing that ptc1 is present in angioblasts prior to tube
formation. (H-K) Transverse sectionw through  7-somite chick embryos.  Note the
expression of Shh in the endoderm (H, filled arrowhead), but not in the dorsal aorta (da).
(I-K) The hedgehog receptors Patched 1 (ptc1) and Patched 2 (ptc2) are present in
endothelial cells of 7-somite embryos, as is smoothened (smo).
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Figure 13. Hedgehog signaling is essential for vascular assembly.
Quail embryos treated with the hedgehog inhibitor cyclopamine (B) have severe
deficiencies in vascular assembly.  Note the lack of dorsal aortae formation (arrows) and
almost complete lack of vascular assembly when compared with embryos treated with
control media (A).
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virtually no discernible patent vessels were detected (Fig. 13B).  In the latter case,
angioblasts remained abundant and were located where blood vessel formation
would normally occur.  No significant vascular defects were observed in control
embryos treated with carrier solution alone (Fig. 13A).  These experiments
demonstrate that interference with hedgehog signaling, using the specific inhibitor
cyclopamine, prevents angioblasts from undergoing normal vascular assembly
and tube formation.
3.4. SHH SIGNALING RESCUES TUBE FORMATION IN THE ABSENCE OF
ENDODERM
Is Shh signaling sufficient to rescue tube formation in the absence of
endoderm?  When beads carrying Shh (3µg/µl) were added to quail embryos from
which the endoderm had been removed, well-formed vascular tubes were
produced in the majority of cases (11/15).  These tubes were typically linear
vessels that formed in close proximity to the surface of the bead (Fig. 14H).
Transverse sections through these embryos indicated that these vessels contained
patent tubes (Fig. 14I).  This effect was not seen in endodermless embryos with
control beads (1/12), which lacked vascular assembly (Fig. 14E).  Moreover, the
punctate clusters of angioblasts present in these embryos did not form tubular
structures (Figs. 14F,G).  The effect of Shh on vascular assembly is highly
specific since no appreciable vascular tube formation was observed when beads
carrying BMP4, Activin, FGF-2, or TGFβ1 were added to endodermless embryos
(data not shown).  One potential explanation for our observations is that Sonic
hedgehog causes increased endothelial cell proliferation, which may be a
requirement of efficient tube formation.  However, two independent lines of
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Figure 14. Sonic hedgehog signaling is sufficient to rescue vascular assembly in the
absence of endoderm.
Endoderm was removed from one half of HH stage 5 quail embryos with the
unmanipulated half serving as an internal control (A).  The embryos were then assayed at
7-8 somites (B).  The control side of embryos contains a robust vascular plexus with
patent tubes (C,D).  In contrast, the side lacking endoderm (asterisks indicate control
beads) contains unassembled clusters of angioblasts (E-G).  Beads containing Shh rescue
vascular assembly (H,I). VEGF causes massive endothelial proliferation, but is not able
to rescue vascular assembly (J,K).  When Shh and VEGF beads (not in field of vision) are
both added, a vascular plexus is formed (L,M).  Note the intersection of two blood
vessels in M. Scale bar, 15µm.
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evidence suggest that this is not the case.  First, the potent vascular mitogen
VEGF is not sufficient to bring about vascular tube formation, in endodermless
embryos, at any dose tested.  Instead, VEGF treatment causes angioblasts to
assemble into broad sheets of QH1 positive tissue in a dosage dependent manner.
These sheets were never observed to form vascular tubes or organize into a
vascular network in either whole embryos or sections (0/32 embryos assayed at
VEGF concentrations of1ng/µl, 10ng/µl and 100ng/µl) (Figs. 14J,K).  Second,
hedgehog signaling does not cause proliferation of endothelial cells in culture
(Pola et al., 2001).
Because the endoderm contains a significant amount of VEGF (Fig. 12B)
we sought to determine whether the addition of VEGF potentiated the effect of
Shh on tube formation.  When a combination of Shh and VEGF beads was added
to endodermless embryos, a robust vascular plexus was generated (6/7 embryos).
In overall appearance, the blood vessels formed in response to combined
Shh/VEGF signaling appeared similar to a wild-type vascular network (Compare
Figs. 14 L,M with Figs. 14C,D), containing many more blood vessels than the
Shh beads alone.  Based on these results, we propose that the hedgehog signaling
pathway instructs angioblasts to form endothelial tubes and that it operates in
parallel with VEGF (Fig. 15).  In this model, VEGF is essential for the
proliferation of normal numbers of angioblasts and apparently for their
aggregation.  However, our results demonstrate that VEGF by itself is not capable
of mediating tube formation.  While Shh still causes tube formation in embryos
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lacking endoderm (and therefore containing a reduced dose of VEGF), the
addition of exogenous VEGF and Shh causes an increase in the number of
available endothelial cells, and therefore an increase in the total number of vessels
that can be made.   If the amount of VEGF is too low, the number of specified
angioblasts would be insufficient to form vessels even in the presence of Shh.
This scenario is supported by a recent study demonstrating that VEGF from the
visceral endoderm is absolutely required for yolk sac vasculogenesis (Damert et
al., 2000).  Sonic hedgehog has also been implicated as an indirect angiogenic
factor in postnatal mice, achieving its effects through activation of the VEGF
pathway (Pola et al., 2001).  However, our studies demonstrate that a simple
epistatic relationship is unlikely during embryonic vasculogenesis and that both
factors are required for assembly of vascular tubes (compare Figs. 14 J,K (VEGF
alone) with Figs. 14 L,M (Shh/VEGF).
3.5. DISCUSSION
While this study is the first to demonstrate a specific requirement for
hedgehog signaling in intraembryonic vascular assembly, several genetic studies
have hinted that hedgehog signaling may be important for vascular development.
For example, mouse embryos ectopically expressing Shh in the dorsal neural tube
display hypervascularization (Rowitch et al., 1999).  Embryoid bodies derived
from ES cells lacking the global hedgehog transducer, smoothened, initially
express endothelial cells markers, however they are unable to form blood islands
(Byrd et al., 2002).  In addition, zebrafish Shh mutants, such as Sonic-you, do not
form vascular tubes in the trunk region of the embryo, although angioblasts are
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Figure 15. Schematic model for vascular assembly.
In wild-type embryos, high levels of VEGF (large red arrows) from mesoderm cause the
proliferation of angioblasts within the tissue layer.  In combination with Sonic hedgehog
(Shh) from the endoderm (blue arrows), these angioblasts assemble into a vascular
network with patent tubes.  When endoderm is experimentally removed from embryos,
angioblasts are still specified, but are unable to organize into a vascular network.  The
addition of Shh beads (blue circles) to  endodermless embryos is sufficient to rescue
vascular assembly.  However, the addition of VEGF beads (red circles) with Shh beads
causes a more complete vascular plexus, suggesting that smaller levels of VEGF in the
endoderm (small red arrows) also play a role in vascular assembly.
ddd
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still present (Brown et al., 2000).  Shh has also been shown to be an upstream
factor mediating arterial identity in zebrafish (Lawon et al., 2002).
At present, the mechanism by which Shh promotes vascular assembly is
completely unknown.  One hypothesis is that Shh mediates the expression of a
cell adhesion molecule.  Shh has been proposed to control cell segregation in the
Drosophila wing imaginal disc by regulating a cell adhesion molecule (Dahmann
and Basler, 2000).  Alternatively, Shh signaling within dental epithelial cells was
recently shown to be necessary for cell polarization (Gritli-Linde et al., 2002).
Shh could be effecting a similar role by causing angioblasts to become polarized,
a necessary prerequisite to tube formation (Hogan and Kolodziej, 2002).
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Chapter 4: Future Directions
4.1. INTRODUCTION
The preceding experiments indicate that contrary to what was previously
thought, endoderm is not necessary for angioblast specification.  However,
endoderm does provide an inductive signal that instructs angioblasts to form
tubes. Our data indicate that Sonic hedgehog (Shh) signaling represents the
critical endodermal factor responsible for vascular tube formation.  These results
raise a number of interesting questions that are addressed below.
4.2. INTRA-MESODERMAL MECHANISMS OF ANGIOBLAST SPECIFICATION
Since endoderm does not induce angioblasts, what signal(s) is responsible
for their formation?  Our experiments suggest that specification of angioblasts
must occur within the mesoderm itself.  The mechanisms of this signal are
currently unknown.  The earliest known endothelial-specific gene, flk-1, first
appears in the mesoderm shortly after the onset of somite formation.  In mouse,
the flk-1 promoter has been shown to contain GATA, ETS and SCL/TAL binding
sites (Kappel et al., 1999).  It has not been shown if these factors are sufficient to
drive flk-1 expression, and it appears likely that additional factors will also be
required.  Thus one clear set of experiments that would help clarify endothelial
specification is to more thoroughly characterize the flk-1 promoter.  Recently,
Xenopus genomic sequences from the proximal flk-1 promoter and first intron
have been shown to be sufficient to drive endothelial-specific expression of GFP
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in Xenopus embryos (Paul Krieg, personal communication).  With this tool, it is
now possible to closely study the regulation of this promoter.  While these
experiments will give important information on how flk-1 is regulated, it is
important to emphasize that the precise role of flk-1 in endothelial specification is
unknown.  Furthermore, other molecules are also likely to be involved in
specifying angioblasts.  Thus, obtaining a comprehensive picture of how
angioblasts are specified is clearly a complex question that will require an
extensive amount of research.
4.3. WHICH TRANSCRIPTION FACTORS ARE MEDIATING HEDGEHOG
SIGNALING IN THE DEVELOPING VASCULATURE?
Another set of questions from these results  concern the mechanism by
which Shh instructs angioblasts to form tubes.  Depending on its cellular context,
hedgehog signaling has been shown to perform a very diverse set of biological
functions.  As a first step towards understanding this process, it will be necessary
to learn which transcription factors are mediating hedgehog signaling in the
developing vasculature. Hedgehog signaling is largely mediated through the
Ci/Gli family of transcription factors, consisting of one Ci protein in Drosophila
and three homologous Gli transcription factors (Gli1-3) in vertebrates.  To
determine which of these genes are involved in mediating hedgehog signaling
during vasculogenesis, it will be necessary to characterize the expression of these
different genes in the developing vasculature of the chick or Xenopus .
Determining the expression of these genes should be relatively straight-forward,
as they are all cloned in both the chick and frog.  The determination of which Gli
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genes are expressed in endothelial cells is potentially important since different Gli
genes as either transcriptional activators or repressors.
4.4. ARE EXPRESSION OF VASCULAR CELL ADHESION MOLECULES
REGULATED BY HEDGEHOG SIGNALING?
An additional question concerning the mechanism of Shh signaling is what
molecules are effecting the processes of vascular assembly.  As mentioned
previously, one possibility is that Shh is regulating the expression or activity of a
cell adhesion molecule.  One of the primary events of tubulogenesis at the cellular
level, is the establishment of cell-cell junctions (Hogan and Kolodziej, 2002), the
formation of which is largely mediated by cell adhesion molecules.  Genetic
studies of Drosophila reveal that at least one cell adhesion molecule (E-cadherin)
is required for tracheal tubulogenesis (Lee and Kolodziej, 2002).  We hypothesize
that expression of endothelial cell adhesion molecules will be altered in the
absence of Shh signaling.  There is precedence for this hypothesis, as clonal
populations of hedgehog expressing cells preferentially co-segregate in
Drosophila abdominal segments (Lawrence et al., 1999).  Furthermore, Hedgehog
has been postulated to regulate a cell adhesion molecule that controls anterior-
posterior compartment sorting in the Drosophila wing imaginal disc (Dahmann
and Basler, 2000).   To test this hypothesis, the expression patterns of VE-
Cadherin and PECAM (another vascular cell adhesion molecule) sequences could
be examined in manipulated embryos.   Alteration of expression of any of these
molecules when hedgehog signaling is perturbed would provide a plausible model
to explain the lack of vascular tube formation.
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4.5. DOES SHH EXPRESSION AT THE EMBRYONIC MIDLINE PLAY A
ROLE IN DORSAL AORTA FORMATION?
The paired dorsal aortae are by far the largest vessels to assemble in the
chick embryo.  They are located immediately ventrolateral to the somites, on
either side of the ventral midline.  As shown in Figs. 12B-D, the highest areas of
expression of Shh in the embryo are located in the notochord and floorplate of the
neural tube.  In Fig. 13, we show that blocking hedgehog activity using
cyclopamine largely eliminates vascular assembly.  However, if any remaining
vessels are visible, they are always located adjacent to the somites, often
consisting of fragments of a small dorsal aorta tube.  Based on these observations,
we hypothesize that Shh expression at the embryonic midline plays a role in
mediating the size of the dorsal aorta.  This question can be addressed
experimentally with embryological approaches that utilize avian embryos to
remove or displace the midline from direct contact with the adjacent somites.
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Chapter 5: Materials and Methods
5.1. EMBRYOLOGICAL MANIPULATIONS.
Xenopus embryos were staged according to Nieuwkoop and Faber (1994).
Animal caps were dissected from stage 8 embryos and cultured in 50% NAM
containing 0.1% BSA and Penicillin-Streptomycin until sibling embryos were at
stage 30.  When applicable, caps were cultured in media containing 100 ng/ml
Xenopus bFGF (a gift from David Kimelman) at 13°C overnight (until sibling
embryos were at stage 12.5), and then transferred 50% NAM to generate a
population of mesoderm completely devoid of endoderm.  While activin treatment
is a more routine method for generating mesodermal populations in animal caps
and is effective in the induction of endothelial cell markers, it also induces the
expression of endodermal genes (data not shown), making these experiments
uninterpretable.  Embryological manipulations were performed using
electrolytically sharpened tungsten needles and hair loops in 75% NAM.
Embryos were subsequently incubated in 50% NAM until the appropriate stage.
Presumptive endoderm was removed from stage 10 embryos as described by
Nascone and Mercola (1995).  In the rescued endodermless embryos, endoderm
was removed as above, and a small core of vegetal mass from a sibling embryo
was inserted into the embryo.  Embryos were then allowed to heal under glass
bridges overnight.
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Stage 5 quail embryos (unless specified) were placed on plastic rings and
endoderm was removed from one half of the embryo using tungsten needles (Fig.
14A).  No enzymatic treatment was used with stage 5 embryos, but older embryos
were dissected in media containing 0.01% trypsin, which was subsequently
inactivated with 0.02% trypsin inhibitor. Embryos were then incubated on New
Cultures (New, 1955) at 37° until the appropriate stage (usually 7-8 somites) (Fig.
14B).  When necessary, heparin acrylic beads (Sigma) were implanted
immediately after endoderm removal.  In these experiments, heparin beads were
rinsed in PBS and soaked for one hour or more in the appropriate concentration of
growth factor on ice.  These beads were then briefly rinsed in PBS before being
implanted in embryos.  For hedgehog inhibition experiments, embryos at 1-2
somites were incubated as New cultures (New, 1955) immersed in DMEM
containing 0.5% ethanol and 100µm cyclopamine (Toronto Research Chemicals
Inc.) or DMEM containing 0.5% ethanol for controls and incubated at 37° in 95%
oxygen until approximately 8 somites.
5.2.  VEGT ANTISENSE-TREATED EMBRYOS.
cDNA from VegT antisense oligonucleotide treated embryos was
generously provided by Matt Kofron and Janet Heasman.  The samples, obtained
following the host-transfer technique, are identical to those used in Kofron et al.
(1999), and represent oocytes injected with 5-8 ng of phosphorothioate antisense
VegT oligos and subsequently implanted into host females prior to fertilization.
Embryos were harvested at stage 34 for RT-PCR analysis.
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5.3.  RT-PCR.
5.3.1.  RT-PCR Conditions.
For experiments involving animal caps, approximately 8 animal caps were
harvested for each sample.  For experiments involving chick embryos,
approximately 8 embryos worth of endoderm, or of lateral plate mesoderm and
somites was collected.  Total RNA was prepared using a standard SDS-Proteinase
K method.  cDNA samples were prepared from one-half of the total RNA (with
the other have serving as a –RT control) and radioactive RT-PCRs (Chapter 2)
were performed using 1/25th of the cDNA reaction as template and 0.3 µCi of
[32P]dATP in a 50µl reaction.  The number of cycles for each primer was
empirically determined so that they would be in the linear range of amplification.
PCR samples were run on non-denaturing 5% acrylamide gels.  In Chapter 3, the
conditions were the same as those above, except that non-radioactive nucleotides
were used in the reactions and the products were electrophoresed on 2% agarose
gels.
5.3.2.  Xenopus RT-PCR Primers
Cardiac α-actin (Niehrs et al., 1994) (Tm = 63°).
Cardiac Troponin I:
Forward: 5’TCGGTCCTATGCCACAGAACCAC3’,




Reverse: 5’CCATTTCCTGCGAGCACAGTAACC3’ (Tm = 62°).
Erg (Detects both isoforms):
Forward: 5’CCTCAACAAGACTGGCTCTCACAG3’,
Reverse: 5’TGCTCCACAAAGTAGGGTCAGC3’ (Tm = 66°).
Flk-1:
Forward: 5’AAGAGGGAACAAGAATGAGGGC3’,
Reverse: 5’TGCTGCTGCTGTGAAGAAACC3’ (Tm = 64°).
IFABP: (Henry et al., 1996) (Tm = 60°).
Insulin (Henry et al., 1996)  (Tm = 63°).
Mixer:
Forward: 5’GCTTTGTTCAGAATCCACCTACGC3’,
Reverse: 5’AGTGATGGTCTTGTTGGGAGGG3’ (Tm = 61°).




Reverse: 5’CAGTTCTGTGGCTGGTGTCAAAG3’ (Tm = 64°).
Xbra:
Forward: 5’GGAGTAATGAGTGCGACCGAGAGC3’,




Reverse: 5’GGATGAAGTTGGCAGAGG3’ (Tm = 65°).
Xsox17- α:
Forward: 5’TGCCAATAATGATGACTGGACTCG3’,
Reverse: 5’TCTTCACCTGTTTCCTCCTGCG3’ (Tm = 61°).







VEGF (core sequence common to all isoforms):
Forward: 5’CAAATTCCTGGAAGTCTACGAACG3’,
Reverse: 5’AATTCTTGCGATCTCCATCGTG3’ (Tm=62°C).
5.4.  IN SITU HYBRIDIZATION AND HISTOLOGY.
Digoxigenin-labeled RNA probe was transcribed using MEGAscript
(Ambion).  Chick, quail and Xenopous  embros were assayed by in situ
hybridization as previously described (Gerber et al 1999) and developed in either
BM-Purple (Roche) or NBT-BCIP (Roche). In situ hybridizations to sections
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(Chapter 3) were performed as described by Grapin-Botton et al (2001).  Paraffin
sections on embryos assayed by wholemount in situ hybridization (Chapter 2)
were carried out by dehydrating the embryos in a graded ethanol series, washing
twice for 10 minutes each in xylene, and then three times in paraplast at 60°C for
a total of 2 hours.  Embryos were then embedded in paraplast and sectioned at a
thickness of 12 µm.  Slides were dewaxed in xylene and viewed by DIC optics.
For plastic sections, embryos were fixed in 1/2 strength Karnovsky’s solution in
0.1 M cacodylate buffer, embedded in Spurr resin, post-fixed in 2% OsO4,
sectioned at a thickness of 1 µm and stained with toluidine blue (semi-thin
histological sections) or 3µm (in situ hybridized sections).  For electron
microscopy imaging, thin sections (approximately 0.06 µm) were stained with
uranyl acetate and lead citrate and imaged on a Philips CM12 transmission
electron microscope.
5.5.  IMMUNOHISTOCHEMISTRY.
Quail endothelial cells were detected with the QH1 monoclonal antibody
(Pardanaud et al., 1987; Developmental Studies Hybridoma Bank).  The
procedure was performed as described by Sugi and Markwald (1996) except that
embryos were blocked in 5% Normal donkey serum and a donkey anti-mouse
Texas Red-conjugated IgG secondary antibody (Jackson ImmunoResearch) was
used at a 1:500 dilution. Immunostained sections were generated by embedding
previously stained embryos in 30% gelatin and fixing overnight in 4%
paraformaldehyde.  Specimens were vibratome sectioned at a thickness of 40µm.
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Sections were then imaged using deconvolution microscopy.  To detect
colocalized QH1 immunostaining and ptc1 expression, in situ hybridization was
performed on 10µm paraffin sections of 6-somite quail embryos, which were
post-fixed prior to antibody staining using standard conditions.
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